https://curecurrent.com/trials/relationship-between-hiv-1-subtype-and-arv-response-132009https://curecurrent.com/trials/safety-and-immunogenicity-of-mva85a-prime-and-bacille-calmette-guerin-boost-vaccination-132010https://curecurrent.com/trials/towards-hiv-functional-cure-132011https://curecurrent.com/trials/being-responsible-for-ourselves-hiv-risk-reduction-for-black-msm-132012https://curecurrent.com/trials/impact-of-an-antibiotic-rifaximin-on-liver-scarring-in-hiv-infected-patients-with-liver-disease-132013https://curecurrent.com/trials/vicriviroc-in-hiv-treatment-experienced-subjects-study-p04405am5-132014https://curecurrent.com/trials/effect-of-hiv-std-risk-reduction-program-on-south-african-adolescents-132015https://curecurrent.com/trials/pneumonia-vaccine-in-aging-hiv-positive-individuals-132016https://curecurrent.com/trials/effects-of-dolutegravir-based-regimen-on-hiv-1-reservoir-and-immune-activation-132017https://curecurrent.com/trials/microboosting-of-atazanavir-300-mg-with-50-mg-versus-100mg-ritonavir-daily-in-hiv-infected-patients-a-pharmacokinetic-st-132018https://curecurrent.com/trials/retrieve-reverse-transcriptase-inhibitor-hiv-practice-132019https://curecurrent.com/trials/patient-retention-in-hiv-medical-care-in-a-primary-care-practice-in-australia-132020https://curecurrent.com/trials/the-role-of-multivitamins-in-pediatric-hiv-management-in-nigeria-132021https://curecurrent.com/trials/pilot-study-of-text-message-reminders-to-improve-hiv-medication-adherence-in-botswana-132022https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-cytomegalovirus-retinitis-retreatment-trial-crrt-132023https://curecurrent.com/trials/the-study-of-gut-associated-lymphocytes-in-hiv-and-hcv-hiv-co-infected-patients-132024https://curecurrent.com/trials/safety-and-pharmacokinetics-of-dapivirine-maraviroc-vaginal-ring-132025https://curecurrent.com/trials/a-south-african-pilot-worksite-parenting-program-to-prevent-hiv-among-adolescents-132026https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-an-investigational-drug-in-hiv-infected-patients-0518-004-completed-132027https://curecurrent.com/trials/study-to-determine-the-effect-of-efavirenz-on-the-ecg-qtcf-interval-in-healthy-subjects-132028https://curecurrent.com/trials/induction-maintenance-of-lopinavir-r-in-hiv-infected-subjects-132029https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-raltegravir-mk0518-in-hiv-infected-patients-failing-current-antiretrovira-132030https://curecurrent.com/trials/comparison-of-plasma-smartplasma-for-human-immunodeficiency-virus-hiv-and-hepatitis-c-virus-hcv-antibody-testing-132031https://curecurrent.com/trials/omega-3-supplementation-in-hiv-patients-with-therapeutic-lifestyle-change-diet-132032https://curecurrent.com/trials/dolutegravir-rilpivirine-switch-study-doriss-132033https://curecurrent.com/trials/cellulose-sulfate-and-hiv-transmission-among-women-132034https://curecurrent.com/trials/rectal-microbicide-safety-and-acceptability-trial-of-topically-applied-tenofovir-compared-with-oral-tablet-132035https://curecurrent.com/trials/hiv-posterior-cheek-enlargement-132036https://curecurrent.com/trials/hiv-sti-prevention-for-adolescents-with-substance-use-disorders-in-treatment-132037https://curecurrent.com/trials/safety-and-immunogenicity-study-of-sev-g-np-hiv-vaccine-administered-intranasally-and-ad35-grin-hiv-vaccine-given-intram-132038https://curecurrent.com/trials/impact-of-hyperbilirubinemia-among-hiv-patients-treated-with-atazanavir-132039https://curecurrent.com/trials/platelets-study-influence-of-the-antiretroviral-treatment-on-the-platelet-physiology-during-hiv-infection-132040https://curecurrent.com/trials/juvenile-offender-hiv-prevention-and-drug-abuse-services-132041https://curecurrent.com/trials/investigation-of-v520-in-a-hiv-vaccine-dose-refinement-study-v520-027-terminated-132042https://curecurrent.com/trials/energy-expenditure-of-people-living-with-hiv-aids-132043https://curecurrent.com/trials/ibrutinib-in-treating-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma-in-patients-with-hiv-infection-132044https://curecurrent.com/trials/the-effect-of-protease-inhibitors-on-the-pharmacokinetics-of-oral-norethindrone-contraception-132045https://curecurrent.com/trials/study-of-nuvaring-acceptability-adherence-and-biological-effects-among-hiv-negative-women-in-kenya-132046https://curecurrent.com/trials/effect-of-omega-3-fatty-acids-on-oxidative-stress-in-hiv-seropositive-patients-132047https://curecurrent.com/trials/text-messaging-to-improve-hiv-testing-among-young-women-in-kenya-132048https://curecurrent.com/trials/evaluation-of-the-dpp-hiv-1-2-test-and-the-hiv-1-2-stat-pak-test-using-oral-fluid-132049https://curecurrent.com/trials/tripterygium-wilfordii-hook-f-twhf-treatment-for-immune-non-responders-with-hiv-1-infection-132050https://curecurrent.com/trials/efavirenz-versus-rilpivirine-on-vascular-function-inflammation-and-oxidative-stress-132051https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-adding-enfuvirtide-to-oral-highly-active-antiretroviral-therapy-haart-in-132052https://curecurrent.com/trials/analysis-of-host-genetic-factors-in-the-occurrence-of-anemia-and-on-the-virological-response-to-a-peg-interferon-ribavir-132053https://curecurrent.com/trials/impaact-p1058a-pharmacokinetic-effects-of-new-antiretroviral-drugs-on-children-adolescents-and-young-adults-132054https://curecurrent.com/trials/immune-response-to-pneumococcal-vaccination-in-hiv-infected-individuals-132055https://curecurrent.com/trials/hepatic-safety-of-eviplera-in-hiv-hepatitis-c-hcv-coinfected-patients-without-hcv-treatment-in-the-the-hepavir-hepatic-s-132056https://curecurrent.com/trials/improving-diagnosis-of-tuberculosis-in-hiv-infected-children-in-asia-cambodia-vietnam-and-africa-burkina-faso-cameroon-132057https://curecurrent.com/trials/optimizing-antiretroviral-therapy-in-hiv-infected-children-and-adolescents-132058https://curecurrent.com/trials/outcomes-of-hiv-infected-individuals-after-ten-years-on-antiretroviral-treatment-132059https://curecurrent.com/trials/prevalence-of-hiv-associated-neurocognitive-disorders-hand-in-a-school-of-medicine-hiv-aids-outpatient-clinic-132060https://curecurrent.com/trials/influence-of-cytochrome-p2b6-on-efavirenz-dose-in-hiv-infected-thai-patients-132061https://curecurrent.com/trials/raltegravir-lopinavir-ritonavir-or-emtricitabine-tenofovir-for-hiv-treatment-naive-subjects-132062https://curecurrent.com/trials/status-of-chronic-liver-disease-in-hepatitis-c-virus-hcv-patients-coinfected-with-human-immunodeficiency-virus-hiv-in-an-132063https://curecurrent.com/trials/effect-of-multiple-dosing-with-bi-201335-on-the-pharmacokinetics-of-darunavir-co-administered-with-ritonavir-in-healthy-132064https://curecurrent.com/trials/drug-drug-interaction-of-bi-201335-and-tenofovir-132065https://curecurrent.com/trials/progesterone-supplementation-for-hiv-positive-pregnant-women-on-anti-retrovirals-132066https://curecurrent.com/trials/study-to-understand-the-natural-history-of-hiv-aids-in-the-era-of-effective-therapy-sun-study-132067https://curecurrent.com/trials/medical-marijuana-use-in-hiv-patients-probability-survey-132068https://curecurrent.com/trials/recovery-management-checkups-for-women-offenders-132069https://curecurrent.com/trials/behavioral-science-aspects-of-rapid-test-acceptance-132070https://curecurrent.com/trials/intralesional-bevacizumab-for-treating-aids-associated-kaposi-s-sarcoma-of-the-larynx-pharynx-and-oral-cavity-132071https://curecurrent.com/trials/resistance-in-hiv-in-north-and-south-132072https://curecurrent.com/trials/integration-of-buprenorphine-into-hiv-clinical-settings-primary-care-model-pcm-132073https://curecurrent.com/trials/effectiveness-of-structured-ecosystems-therapy-for-reducing-hiv-risk-behaviors-and-improving-treatment-adherence-in-hiv-132074https://curecurrent.com/trials/gamma-secretase-inhibitor-pf-03084014-in-treating-patients-with-aids-associated-kaposi-sarcoma-132075https://curecurrent.com/trials/accuracy-of-the-pima-cd4-test-for-enumeration-of-cd4-t-cell-counts-132076https://curecurrent.com/trials/isentress-re-examination-study-mk-0518-115-132077https://curecurrent.com/trials/stocrin-re-examination-study-0831-028-132078https://curecurrent.com/trials/safety-and-efficacy-of-tenofovir-df-in-hiv-1-infected-adolescents-failing-their-current-antiretroviral-therapy-132079https://curecurrent.com/trials/relative-bioavailability-study-of-phase-iii-tablet-formulation-of-cabotegravir-132080https://curecurrent.com/trials/boceprevir-drug-combination-for-hepatitis-c-treatment-in-people-with-and-without-hiv-132081https://curecurrent.com/trials/exploring-hiv-entry-blockade-as-a-pre-exposure-prophylaxis-strategy-in-women-132082https://curecurrent.com/trials/demand-creation-for-couples-hiv-counseling-and-testing-132083https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-of-an-oral-contraceptive-containing-levonorgestrel-and-ethinyl-estradiol-when-co-132084https://curecurrent.com/trials/tmc114-c214-trial-of-tmc114-administered-with-low-dose-ritonavir-rtv-in-hiv-1-infected-treatment-experienced-patients-132085https://curecurrent.com/trials/clinical-trial-of-safety-and-pharmacokinetics-of-vm-1500-after-multiple-oral-administration-in-healthy-volunteers-132086https://curecurrent.com/trials/measuring-the-impact-of-integrating-maternal-and-newborn-hiv-testing-with-childhood-immunization-services-132087https://curecurrent.com/trials/study-of-immunity-at-the-genital-mucosa-of-hiv-1-infected-and-healthy-women-132088https://curecurrent.com/trials/study-of-safety-and-pharmacokinetics-in-healthy-volunteers-and-safety-tolerability-and-antiviral-activity-of-vm-1500-in-132089https://curecurrent.com/trials/a-phase-ii-trial-to-assess-the-safety-and-immunogenicity-of-dna-priming-administered-by-the-id-zetajet-with-or-without-i-132090https://curecurrent.com/trials/pi-or-nnrti-as-first-line-treatment-of-hiv-in-west-africa-the-piona-trial-132091https://curecurrent.com/trials/evaluation-of-the-quality-of-self-collected-blood-spot-specimens-for-laboratory-hiv-testing-an-involvement-sub-study-132092https://curecurrent.com/trials/project-n-liten-hiv-prevention-for-african-american-women-132093https://curecurrent.com/trials/clinical-study-of-an-aluvia-based-haart-regimen-for-prevention-of-mother-to-child-hiv-transmission-in-africa-132094https://curecurrent.com/trials/pilot-assessment-of-lopinavir-ritonavir-and-maraviroc-132095https://curecurrent.com/trials/internet-based-sexual-health-education-for-middle-school-native-american-youth-132096https://curecurrent.com/trials/the-navigator-project-132097https://curecurrent.com/trials/longitudinal-study-of-ocular-complications-of-aids-lsoca-132098https://curecurrent.com/trials/switch-from-tenofovir-to-raltegravir-for-low-bone-mineral-density-132099https://curecurrent.com/trials/evaluation-of-behavioral-intervention-for-hiv-positive-prisoners-in-nc-and-tx-132100https://curecurrent.com/trials/brief-intervention-for-drug-misuse-in-the-emergency-department-132101https://curecurrent.com/trials/raltegravir-added-to-stable-haart-in-hiv-1-infected-subjects-with-viral-suppression-and-low-cd4-recovery-132102https://curecurrent.com/trials/antiretroviral-adherence-and-quality-of-life-support-for-hiv-patients-in-india-with-twice-daily-interactive-voice-respon-132103https://curecurrent.com/trials/hormone-replacement-therapy-and-anti-hiv-drugs-in-hiv-infected-postmenopausal-women-132104https://curecurrent.com/trials/a-study-to-see-if-certain-antioxidants-and-vitamins-will-keep-lactate-levels-down-in-patients-taking-anti-hiv-drugs-132105https://curecurrent.com/trials/stribild-in-non-nucleoside-resistant-patients-sinnr-study-132106https://curecurrent.com/trials/a-trial-of-the-urine-lam-strip-test-for-tb-diagnosis-amongst-hospitalized-hiv-infected-patients-132107https://curecurrent.com/trials/early-antiretroviral-treatment-and-or-early-isoniazid-prophylaxis-against-tuberculosis-in-hiv-infected-adults-anrs-12136-132108https://curecurrent.com/trials/safety-study-of-raltegravir-in-hiv-hcv-co-infected-patients-132109https://curecurrent.com/trials/familias-unidas-preventing-substance-abuse-in-hispanic-youth-132110https://curecurrent.com/trials/behavioral-clinical-and-basic-science-studies-of-non-occupational-post-exposure-prophylaxis-pep-2-132111https://curecurrent.com/trials/the-role-of-inflammation-and-aging-in-hiv-associated-cardiovascular-risk-132112https://curecurrent.com/trials/observational-study-of-nevirapine-extended-release-in-human-immunodeficiency-virus-hiv-patients-in-daily-clinical-practi-132113https://curecurrent.com/trials/strategies-to-increase-hiv-testing-linkages-to-care-and-male-circumcision-in-africa-132114https://curecurrent.com/trials/addressing-psychosocial-needs-and-hiv-risk-in-indian-msm-132115https://curecurrent.com/trials/hiv-educational-programs-for-villagers-of-funan-county-or-yingzhou-district-anhui-province-china-132116https://curecurrent.com/trials/male-partner-involvement-in-the-prevention-of-mtct-of-hiv-132117https://curecurrent.com/trials/perceptions-of-burden-in-patients-with-late-stage-cancer-and-their-caregivers-132118https://curecurrent.com/trials/effect-of-bednets-and-a-water-purification-device-on-hiv-disease-progression-among-art-na-ve-patients-in-kenya-132119https://curecurrent.com/trials/microbicide-safety-and-acceptability-in-young-men-132120https://curecurrent.com/trials/ucla-amity-parolee-health-promotion-study-132121https://curecurrent.com/trials/a-72-week-randomized-clinical-trial-comparing-the-safety-and-efficacy-of-three-initial-antiretroviral-regimens-gpo-vir-s-132122https://curecurrent.com/trials/a-study-of-safety-tolerability-and-immunogenicity-of-a-1-dose-regimen-of-mrkad5-hiv-1-gag-vaccine-versus-the-alvac-hiv-v-132123https://curecurrent.com/trials/a-study-to-explore-the-association-between-blood-pressure-hiv-and-antiretroviral-therapy-132124https://curecurrent.com/trials/evaluating-the-effect-of-a-novel-web-based-intervention-to-increase-hiv-testing-in-men-who-have-sex-with-men-132125https://curecurrent.com/trials/factors-affecting-the-intention-to-take-npep-among-thai-msm-132126https://curecurrent.com/trials/serosorting-intervention-for-hiv-negative-msm-132127https://curecurrent.com/trials/cohort-study-of-hiv-1-incidence-among-clients-of-the-thai-red-cross-aids-research-center-bangkok-thailand-132128https://curecurrent.com/trials/safer-sex-intervention-for-male-clients-of-female-sex-workers-in-tijuana-mexico-132129https://curecurrent.com/trials/implementation-of-an-efficacious-intervention-for-high-risk-women-in-mexico-132130https://curecurrent.com/trials/culturally-sensitive-intervention-to-improve-retention-in-hiv-care-for-latino-msm-132131https://curecurrent.com/trials/effects-of-hiv-and-hepatitis-c-virus-on-the-brain-132132https://curecurrent.com/trials/determining-the-effect-of-abacavir-on-platelet-activation-132133https://curecurrent.com/trials/in-vivo-drug-interaction-pharmacokinetic-study-of-tenofovir-1-gel-and-three-commonly-used-vaginal-products-132134https://curecurrent.com/trials/hiv-testing-strategies-in-the-perinatal-setting-132135https://curecurrent.com/trials/couples-hiv-counseling-and-testing-for-male-couples-in-the-united-states-132136https://curecurrent.com/trials/atorvastatin-for-haart-suboptimal-responders-132137https://curecurrent.com/trials/family-centered-advanced-care-planning-for-adolescents-with-hiv-aids-and-their-families-132138https://curecurrent.com/trials/adjunct-immunotherapy-with-immunoxel-in-patients-with-tb-and-tb-hiv-132139https://curecurrent.com/trials/an-evaluation-of-the-pharmacological-interaction-of-lopinavir-r-and-rifampin-132140https://curecurrent.com/trials/antiviral-therapy-and-hiv-in-the-female-genital-tract-132141https://curecurrent.com/trials/intervention-development-for-social-stress-mental-health-and-hiv-risk-msm-132142https://curecurrent.com/trials/effects-of-ribavirin-on-zidovudine-or-stavudine-132143https://curecurrent.com/trials/salvage-treatment-resistance-testing-and-withdrawal-of-anti-hiv-drugs-for-hiv-patients-failing-current-anti-hiv-treatmen-132144https://curecurrent.com/trials/raltegravir-activity-in-lymphoid-tissues-132145https://curecurrent.com/trials/four-drug-combination-therapy-with-zidovudine-lamivudine-1592u89-abacavir-and-141w94-amprenavir-in-hiv-infected-patients-132146https://curecurrent.com/trials/effectiveness-of-interleukin-2-il-2-plus-anti-hiv-therapy-in-hiv-positive-patients-132147https://curecurrent.com/trials/pilot-study-acceptability-feasibility-and-efficacy-of-vaginal-insemination-in-hiv-discordant-couples-female-positive-mal-132148https://curecurrent.com/trials/hiv-screening-take-up-evaluating-incentives-and-opt-out-strategies-132149https://curecurrent.com/trials/examination-of-b-cell-responses-in-human-blood-132150https://curecurrent.com/trials/investigation-of-the-effect-of-cenicriviroc-cvc-plus-ftc-tdf-on-cardiovascular-disease-risk-factors-132151https://curecurrent.com/trials/pilot-study-of-immediate-hiv-treatment-in-guangxi-china-132152https://curecurrent.com/trials/reducing-cardiovascular-disease-cvd-risk-in-hiv-on-antiretroviral-therapy-over-12-months-132153https://curecurrent.com/trials/simplification-to-atazanavir-ritonavir-lamivudine-as-maintenance-therapy-132154https://curecurrent.com/trials/epidemic-history-and-iatrogenic-transmission-of-blood-borne-viruses-in-mid-20th-century-kinshasa-132155https://curecurrent.com/trials/pilot-study-of-raltegravir-switch-to-resolve-tenofovir-induced-proteinuria-132156https://curecurrent.com/trials/project-teach-kenya-132157https://curecurrent.com/trials/project-aware-using-the-emergency-department-ed-to-prevent-sexually-transmitted-infections-stis-in-youth-132158https://curecurrent.com/trials/incidence-of-oral-candidiasis-prevalence-of-c-dubliniensis-in-hiv-patients-and-in-vitro-azole-susceptibility-132159https://curecurrent.com/trials/client-centered-counseling-during-routine-opt-out-hiv-testing-in-uganda-132160https://curecurrent.com/trials/the-feasibility-of-using-a-general-health-screen-to-increase-hiv-testing-in-community-pharmacies-132161https://curecurrent.com/trials/pharmacokinetic-interactions-between-an-herbal-medicine-african-potato-and-antiretroviral-agents-lopinavir-ritonavir-132162https://curecurrent.com/trials/genetically-modified-peripheral-blood-stem-cell-transplant-in-treating-patients-with-hiv-associated-non-hodgkin-or-hodgk-132163https://curecurrent.com/trials/trial-of-tdf-ftc-raltegravir-versus-tdf-ftc-efavirenz-in-hiv-1-infected-women-132164https://curecurrent.com/trials/safety-and-immunogenicity-study-of-aids-vaccine-combined-use-of-dna-vaccine-and-recombinant-vaccinia-virus-tiantan-132165https://curecurrent.com/trials/impact-of-rutf-on-body-composition-anemia-and-zinc-status-of-plwha-132166https://curecurrent.com/trials/aging-hiv-aids-neurocognitive-sequelae-and-functional-consequences-132167https://curecurrent.com/trials/safety-and-acceptability-of-tenofovir-1-gel-in-adolescent-females-132168https://curecurrent.com/trials/a-phase-3-open-label-study-to-investigate-the-efficacy-and-safety-of-sofosbuvir-plus-ribavirin-in-chronic-genotype-1-2-3-132169https://curecurrent.com/trials/liposomal-daunorubicin-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132170https://curecurrent.com/trials/risk-of-cv-events-with-efv-vs-efv-free-regimens-132171https://curecurrent.com/trials/clinical-performance-of-reveal-g4-rapid-hiv-1-antibody-test-132172https://curecurrent.com/trials/tmc125-tidp35-c213-safety-and-antiviral-activity-of-etravirine-tmc125-in-treatment-experienced-hiv-infected-children-and-132173https://curecurrent.com/trials/antidepressant-treatment-of-aids-related-depression-132174https://curecurrent.com/trials/csp-512-options-in-management-with-anti-retrovirals-132175https://curecurrent.com/trials/hiv-prevention-within-high-risk-bulgarian-and-hungarian-social-networks-132176https://curecurrent.com/trials/feasibility-of-non-pharmacological-insomnia-therapy-in-people-living-with-hiv-132177https://curecurrent.com/trials/the-pediatric-hiv-nutrition-study-in-uganda-132178https://curecurrent.com/trials/safety-and-effectiveness-of-tenofovir-gel-in-the-prevention-of-human-immunodeficiency-virus-hiv-1-infection-in-women-and-132179https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetic-profile-how-the-body-absorbs-distributes-metabolizes-and-eliminates-a-drug-of-tm-132180https://curecurrent.com/trials/adapting-and-evaluating-an-ebi-to-prevent-hiv-aids-risk-among-apache-youth-132181https://curecurrent.com/trials/effectiveness-of-clinician-client-centered-counseling-on-sexual-behaviors-of-antiretroviral-therapy-patients-in-nigeria-132182https://curecurrent.com/trials/directly-administered-antiretroviral-therapy-daart-among-hiv-1infected-injecting-drug-users-idus-in-chennai-india-132183https://curecurrent.com/trials/directly-administered-hiv-therapy-in-methadone-clinics-132184https://curecurrent.com/trials/rapid-evaluation-of-pandemic-h1n1-influenza-vaccine-in-adults-with-hiv-132185https://curecurrent.com/trials/comparison-of-hiv-clinic-based-treatment-with-buprenorphine-versus-referred-care-in-heroin-dependent-participants-132186https://curecurrent.com/trials/randomized-controlled-trial-using-patient-reported-outcomes-and-care-managers-to-improve-hiv-medication-adherence-in-rou-132187https://curecurrent.com/trials/immune-responses-in-patients-treated-with-raltegravir-132188https://curecurrent.com/trials/evaluation-of-the-pharmacokinetics-of-antituberculosis-drugs-and-tuberculosis-treatment-outcomes-132189https://curecurrent.com/trials/influence-of-reproductive-cycle-and-menopause-on-hiv-1-infection-and-tfv-gel-activity-132190https://curecurrent.com/trials/paper-applicator-acceptability-study-132191https://curecurrent.com/trials/contraception-and-menstrual-cycle-effect-on-pharmacokinetics-pharmacodynamics-and-safety-in-tenofovir-vaginal-gel-use-132192https://curecurrent.com/trials/study-of-investigational-regimen-combining-fda-approved-hiv-drugs-in-hiv-subjects-experiencing-early-virologic-failure-132193https://curecurrent.com/trials/intervention-to-assist-msm-disclose-hiv-status-to-casual-sex-partners-132194https://curecurrent.com/trials/improving-hiv-screening-with-nurse-based-rapid-testing-streamlined-counseling-132195https://curecurrent.com/trials/health-values-and-spirituality-in-veterans-with-hiv-aids-132196https://curecurrent.com/trials/a-medication-adherence-intervention-for-hiv-infected-veterans-132197https://curecurrent.com/trials/measuring-hiv-quality-of-care-132198https://curecurrent.com/trials/body-image-and-self-care-in-hiv-infected-msm-132199https://curecurrent.com/trials/examining-hair-to-determine-tenofovir-exposure-132200https://curecurrent.com/trials/kaiser-permanente-hiv-cohort-study-132201https://curecurrent.com/trials/safety-pharmacokinetics-pharmacodynamics-and-disintegration-time-of-vaginal-tablets-containing-tenofovir-and-or-emtricit-132202https://curecurrent.com/trials/effectiveness-of-a-cell-phone-based-program-for-abstinence-and-hiv-risk-prevention-132203https://curecurrent.com/trials/project-hope-hospital-visit-is-an-opportunity-for-prevention-and-engagement-with-hiv-positive-crack-users-132204https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-the-hiv-1-vaccine-mva-b-in-chronic-hiv-1-infected-patients-successfully-treated-with-h-132205https://curecurrent.com/trials/a-pilot-study-for-toxicity-evaluation-of-hiv-rectal-microbicides-132206https://curecurrent.com/trials/study-comparing-two-alternatives-of-antiretroviral-therapy-as-post-exposure-prophylaxis-to-hiv-1-tenofovir-emtricitabine-132207https://curecurrent.com/trials/hpv-in-adolescents-132208https://curecurrent.com/trials/tenofovir-in-hiv-hbv-coinfection-132209https://curecurrent.com/trials/enhancing-communication-and-hiv-outcomes-132210https://curecurrent.com/trials/effects-of-endocrine-health-on-mental-performance-of-men-and-women-using-drugs-132211https://curecurrent.com/trials/study-comparing-two-alternatives-of-antiretroviral-therapy-as-post-exposure-prophylaxis-to-hiv-1-fovir-emtricitabina-lop-132212https://curecurrent.com/trials/open-label-pilot-study-of-darunavir-boosted-by-cobicistat-in-combination-with-rilpivirine-to-treat-hiv-na-ve-subjects-132213https://curecurrent.com/trials/pk-tdf-in-thai-hiv-infected-children-132214https://curecurrent.com/trials/comparing-the-effectiveness-between-ritonavir-boosted-atazanavir-and-efavirenz-for-the-first-hiv-treatment-132215https://curecurrent.com/trials/pharmacokinetic-and-efficacy-of-sqv-r-1500-100-plus-tenofovir-emtricitabine-300-200-mg-132216https://curecurrent.com/trials/comparison-of-epzicom-and-truvada-for-the-initial-once-daily-hiv-treatment-132217https://curecurrent.com/trials/comparing-continuing-tenofovir-emtricitabine-or-lamivudine-plus-lopinavir-and-switching-to-raltegravir-plus-darunavir-132218https://curecurrent.com/trials/a-pk-and-salvage-study-for-children-with-hiv-infection-132219https://curecurrent.com/trials/helping-hiv-infected-patients-in-south-africa-adhere-to-drug-regimens-132220https://curecurrent.com/trials/simultaneous-versus-sequential-antiretroviral-therapy-arv-therapy-and-mycobacterium-tuberculosis-mtb-treatment-132221https://curecurrent.com/trials/rapid-hiv-testing-and-counseling-in-high-risk-women-in-shelters-132222https://curecurrent.com/trials/bioequivalence-study-of-generic-gpo-saquinavir-and-norvir-versus-invirase-and-norvir-132223https://curecurrent.com/trials/lopinavir-ritonavir-lpv-r-tablet-in-hiv-infected-children-132224https://curecurrent.com/trials/lopinavir-ritonavir-monotherapy-in-children-132225https://curecurrent.com/trials/phase-ii-randomized-study-of-physiologic-testosterone-replacement-in-premenopausal-hiv-positive-women-132226https://curecurrent.com/trials/evaluating-the-safety-and-priming-response-of-an-hiv-vaccine-regimen-in-healthy-hiv-uninfected-adults-132227https://curecurrent.com/trials/pediatric-study-for-appropriate-dose-of-ritonavir-boosted-lopinavir-in-thai-hiv-infected-children-pearl-132228https://curecurrent.com/trials/conventional-vaccine-and-intradermal-vaccine-among-hiv-infected-young-subjects-132229https://curecurrent.com/trials/impaact-p1074-long-term-outcomes-in-hiv-infected-infants-children-and-adolescents-132230https://curecurrent.com/trials/enhanced-prevention-in-couples-feasibility-study-2-132231https://curecurrent.com/trials/enhanced-hiv-prevention-in-couples-feasibility-study-1-132232https://curecurrent.com/trials/study-to-evaluate-changes-in-cd4-on-replacing-tdf-with-abc-or-ddi-tdf-with-abc-3tc-132233https://curecurrent.com/trials/the-first-failure-study-132234https://curecurrent.com/trials/hiv-medication-adherence-in-underserved-populations-132235https://curecurrent.com/trials/the-mochudi-prevention-project-art-protocol-132236https://curecurrent.com/trials/a-study-of-dementia-and-neurological-problems-in-hiv-infected-patients-who-are-participating-in-actg-a5175-132237https://curecurrent.com/trials/assessing-hiv-related-oral-mucosal-disease-and-using-saliva-to-measure-viral-load-132238https://curecurrent.com/trials/observational-study-of-specificity-of-mycobacterium-tuberculosis-screening-and-diagnostics-in-hiv-infected-individuals-132239https://curecurrent.com/trials/evaluating-a-microfinance-intervention-for-high-risk-women-in-mongolia-132240https://curecurrent.com/trials/improving-effective-contraceptive-use-among-opioid-maintained-women-132241https://curecurrent.com/trials/a-study-to-treat-subjects-with-telaprevir-ribavirin-and-peginterferon-who-are-coinfected-with-hiv-and-hepatitis-c-virus-132242https://curecurrent.com/trials/phase-1-dose-escalation-study-of-autologous-t-cells-genetically-modified-at-the-ccr5-gene-by-zinc-finger-nucleases-in-hi-132243https://curecurrent.com/trials/atazanavir-and-lamivudine-for-treatment-simplification-132244https://curecurrent.com/trials/pilot-opened-trial-in-hiv-infected-patients-including-an-investigational-marketed-product-132245https://curecurrent.com/trials/safety-and-efficacy-study-of-cp-675-206-in-hiv-infected-patients-132246https://curecurrent.com/trials/efficacy-and-safety-of-temazepam-in-hiv-seropositive-patients-with-insomnia-132247https://curecurrent.com/trials/effect-of-a-change-in-hiv-therapy-on-liver-steatosis-inflammation-and-fibrosis-132248https://curecurrent.com/trials/increasing-haart-induced-immune-restoration-with-cyclosporine-132249https://curecurrent.com/trials/score-system-for-prediction-risk-and-early-diagnosis-of-hcc-in-hiv-hcv-patients-132250https://curecurrent.com/trials/standard-antiretroviral-v-multi-class-therapy-in-acutely-hiv-1-infected-antiretroviral-na-ve-subjects-adarc-2007-01-132251https://curecurrent.com/trials/metformin-for-hiv-inflammation-132252https://curecurrent.com/trials/rapid-hiv-testing-for-emergency-department-patients-132253https://curecurrent.com/trials/a-comparison-of-nelfinavir-plus-saquinavir-plus-delavirdine-or-3tc-zdv-versus-nelfinavir-plus-3tc-zdv-in-hiv-infected-pa-132254https://curecurrent.com/trials/use-of-endopat-for-measurements-of-endothelial-dysfunction-in-hiv-infected-children-and-healthy-controls-132255https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-an-hiv-vaccine-for-hiv-positive-patients-receiving-anti-hiv-drugs-for-at-leas-132256https://curecurrent.com/trials/optimal-treatment-for-kidney-disease-in-hiv-infected-adults-132257https://curecurrent.com/trials/a-study-of-patients-who-recently-have-been-infected-with-hiv-132258https://curecurrent.com/trials/evaluation-of-specific-infection-fighting-cells-for-prediction-of-immune-response-to-anti-hiv-and-immune-boosting-medica-132259https://curecurrent.com/trials/effectiveness-of-adding-interleukin-2-to-anti-hiv-drugs-in-patients-recently-infected-with-hiv-132260https://curecurrent.com/trials/intervention-for-those-recently-informed-of-seropositive-status-iriss-132261https://curecurrent.com/trials/a-randomized-trial-of-iud-versus-hormonal-contraception-in-hiv-infected-women-in-zambia-132262https://curecurrent.com/trials/evaluation-of-healing-at-three-time-intervals-and-potential-for-spontaneous-detachment-132263https://curecurrent.com/trials/thistle-the-hiv-hcv-silibinin-trial-132264https://curecurrent.com/trials/evaluation-of-residual-platelet-reactivity-after-acute-coronary-syndrome-st-st-in-hiv-132265https://curecurrent.com/trials/first-study-to-evaluate-the-capacity-of-maraviroc-drug-to-protect-against-hiv-infection-in-samples-of-rectal-mucosa-from-132266https://curecurrent.com/trials/effectiveness-of-the-diaphragm-for-hiv-prevention-132267https://curecurrent.com/trials/genetic-predictors-of-raltegravir-penetration-into-cerebrospinal-fluid-132268https://curecurrent.com/trials/a-phase-i-trial-of-intranasal-peptide-t-safety-toxicity-and-pharmacokinetics-in-human-immunodeficiency-virus-1-hiv-1-inf-132269https://curecurrent.com/trials/a-phase-i-trial-of-peptide-t-efficacy-for-the-neuropsychiatric-complications-of-acquired-immunodeficiency-syndrome-aids-132270https://curecurrent.com/trials/trial-to-improve-access-to-pmtct-services-and-reduce-hiv-transmission-from-mother-to-child-132271https://curecurrent.com/trials/breather-penta-16-short-cycle-therapy-sct-5-days-on-2-days-off-in-young-people-with-chronic-hiv-infection-132272https://curecurrent.com/trials/a-worldwide-phase-i-dose-escalating-study-of-a-3-dose-regimen-of-the-mrkad5-clade-b-vaccine-in-healthy-adults-v520-018-132273https://curecurrent.com/trials/interaction-study-to-assess-the-pharmacokinetic-interaction-of-oral-administration-of-rifapentine-on-atripla-in-hiv-pati-132274https://curecurrent.com/trials/oral-auranofin-for-reduction-of-latent-viral-reservoir-in-patients-with-hiv-infection-132275https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-and-antiviral-activity-of-dolutegravir-in-the-central-nervous-system-in-hiv-1-infected-a-132276https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-a-single-tablet-regimen-of-emtricitabine-rilpivirine-tenofovir-disoproxil-f-132277https://curecurrent.com/trials/promise-ebf-safety-and-efficacy-of-exclusive-breastfeeding-promotion-in-the-era-of-hiv-in-sub-saharan-africa-132278https://curecurrent.com/trials/effect-of-vicriviroc-on-hiv-ribonucleic-acid-rna-levels-in-cerebrospinal-fluid-study-p05241-132279https://curecurrent.com/trials/atazanavir-ritonavir-once-daily-raltegravir-twice-daily-switch-study-in-hiv-1-infected-patients-132280https://curecurrent.com/trials/post-marketing-surveillance-of-hiv-infected-patients-with-chronic-hepatitis-c-treated-with-pegintron-pen-and-rebetol-stu-132281https://curecurrent.com/trials/substance-use-disorders-in-hiv-people-of-cameroon-132282https://curecurrent.com/trials/determining-the-barriers-and-motivations-to-clinical-trial-participation-132283https://curecurrent.com/trials/antiviral-activity-of-peg-ifn-alpha-2a-in-chronic-hiv-1-infection-132284https://curecurrent.com/trials/behavioral-counseling-intervention-trial-to-reduce-alcohol-related-sexual-risk-behavior-among-hiv-negative-men-in-namibi-132285https://curecurrent.com/trials/preparedness-study-hpv-vaccine-132286https://curecurrent.com/trials/efficacy-and-safety-of-vicriviroc-in-hiv-infected-treatment-na-ve-subjects-study-p04875-132287https://curecurrent.com/trials/registry-to-assess-long-term-outcome-in-hiv-subjects-who-participated-in-phase-2-and-3-clinical-trials-involving-vicrivi-132288https://curecurrent.com/trials/intradermal-versus-intramuscular-polio-vaccine-booster-in-hiv-infected-subjects-132289https://curecurrent.com/trials/family-planning-knowledge-attitudes-and-practices-of-postpartum-malawian-women-132290https://curecurrent.com/trials/raltegravir-switch-for-toxicity-or-adverse-events-132291https://curecurrent.com/trials/a-study-of-safety-tolerability-and-immunogenicity-of-the-mrkad5-gag-pol-nef-vaccine-in-healthy-adults-v520-016-132292https://curecurrent.com/trials/phase-i-iia-dose-escalation-clinical-study-of-vac-3s-132293https://curecurrent.com/trials/effect-of-rosuvastatin-on-endothelial-function-132294https://curecurrent.com/trials/innove-study-a-study-of-3-months-induction-with-fuzeon-enfuvirtide-optimized-background-ob-versus-ob-alone-in-hiv-1-infe-132295https://curecurrent.com/trials/safety-and-immunogenicity-study-of-recombinant-modified-vaccinia-virus-ankara-mva-virus-to-treat-hiv-infection-132296https://curecurrent.com/trials/open-label-pilot-study-to-evaluate-switching-from-a-regimen-consisting-of-raltegravir-plus-emtricitabine-tenofovir-df-fi-132297https://curecurrent.com/trials/stepping-stones-program-for-preventing-hiv-infection-in-residents-of-rural-south-african-communities-132298https://curecurrent.com/trials/a-pilot-study-to-examine-efficacy-of-peer-mentoring-in-promoting-medication-adherence-among-people-living-with-hiv-aids-132299https://curecurrent.com/trials/improving-uptake-of-early-infant-diagnosis-of-hiv-for-the-prevention-of-mother-to-child-transmission-of-hiv-132300https://curecurrent.com/trials/non-interventional-observational-study-with-viramune-in-hiv-to-evaluate-gender-specific-data-132301https://curecurrent.com/trials/use-of-the-shang-ring-circumcision-device-in-boys-below-18-years-old-in-kenya-132302https://curecurrent.com/trials/representations-and-acceptability-of-hiv-therapeutic-vaccine-in-a-cohort-of-hiv-1-infected-outpatients-followed-at-hospi-132303https://curecurrent.com/trials/non-interventional-observational-study-with-viramune-plus-antiretroviral-in-hiv-infected-patients-132304https://curecurrent.com/trials/the-safety-and-effectiveness-of-clarithromycin-in-the-prevention-of-mycobacterium-avium-complex-mac-infection-in-hiv-inf-132305https://curecurrent.com/trials/text-messaging-to-improve-adherence-to-clinic-visits-and-reduce-early-resumption-of-sexual-intercourse-after-male-circum-132306https://curecurrent.com/trials/a-study-of-decreased-mental-function-associated-with-hiv-132307https://curecurrent.com/trials/the-safety-and-effectiveness-of-clarithromycin-plus-ethambutol-used-with-or-without-clofazimine-in-the-treatment-of-mac-132308https://curecurrent.com/trials/efficacy-and-tolerance-of-peg-interferon-alpha-2a-added-to-tenofovir-and-emtricitabine-in-aghbe-positive-hbv-hiv-co-infe-132309https://curecurrent.com/trials/prediction-and-pathogenesis-of-the-immune-reconstitution-inflammatory-syndrome-132310https://curecurrent.com/trials/efficacy-of-pegylated-interferon-plus-ribavirin-plus-nitazoxanide-in-hcv-genotype-4-and-hiv-coinfection-132311https://curecurrent.com/trials/developing-and-assessing-a-community-based-model-of-antiretroviral-care-132312https://curecurrent.com/trials/immunogenicity-and-safety-of-different-dosing-schedules-of-trivalent-influenza-vaccine-in-hiv-infected-pregnant-women-132313https://curecurrent.com/trials/safety-tolerability-and-adherence-to-co-formulated-tenofovir-emtricitabine-rilpivirine-used-as-hiv-nonoccupational-post-132314https://curecurrent.com/trials/therapeutic-schools-affect-management-and-hiv-prevention-132315https://curecurrent.com/trials/post-prandial-lipid-effects-of-raltegravir-ral-vs-ritonavir-boosted-darunavir-drv-r-in-anti-retroviral-therapy-art-naive-132316https://curecurrent.com/trials/immunogenicity-and-safety-of-trivalent-influenza-vaccine-in-pregnant-and-nonpregnant-hiv-uninfected-women-132317https://curecurrent.com/trials/male-engagement-in-pmtct-services-132318https://curecurrent.com/trials/alcohol-harm-reduction-intervention-among-female-sex-workers-in-mombasa-kenya-132319https://curecurrent.com/trials/pilot-placebo-controlled-study-with-lovaza-in-cardiovascular-disease-132320https://curecurrent.com/trials/safety-and-efficacy-of-salsalate-to-treat-endothelial-dysfunction-in-hiv-infected-adults-132321https://curecurrent.com/trials/evaluation-of-the-effects-of-a-structural-economic-and-food-security-intervention-on-hiv-vulnerability-in-rural-malawi-132322https://curecurrent.com/trials/a-group-level-intervention-to-reduce-hiv-sti-risk-for-women-who-have-sex-with-women-in-calgary-and-toronto-132323https://curecurrent.com/trials/raltegravir-vs-atazanavir-in-combination-with-truvada-for-the-treatment-of-antiretroviral-na-ve-hiv-infected-patients-132324https://curecurrent.com/trials/mirtazapine-to-reduce-methamphetamine-use-among-msm-with-high-risk-hiv-behaviors-132325https://curecurrent.com/trials/mid-life-women-preventing-unintended-pregnancy-and-stis-132326https://curecurrent.com/trials/a-drug-interaction-study-evaluating-plasma-gsk2248761-and-gsk1349572-pharmacokinetics-in-healthy-adult-subjects-132327https://curecurrent.com/trials/post-marketing-safety-surveillance-program-in-human-immunodeficiency-virus-hiv-infected-children-exposed-to-atazanavir-i-132328https://curecurrent.com/trials/isolated-anti-hbc-serological-profile-in-hiv-infected-patients-immunological-virological-characteristics-and-response-to-132329https://curecurrent.com/trials/safety-and-efficacy-of-bay-50-4798-in-patients-with-hiv-infection-132330https://curecurrent.com/trials/intervention-to-reduce-injection-drug-use-132331https://curecurrent.com/trials/drug-use-investigation-of-kaletra-tablets-once-daily-administration-on-patients-with-hiv-infection-132332https://curecurrent.com/trials/levels-of-raltegravir-in-the-female-genital-tissue-132333https://curecurrent.com/trials/antiretrovirals-and-rate-of-progression-in-carotid-artery-intima-medial-thickness-in-hiv-132334https://curecurrent.com/trials/a-pilot-raltegravir-versus-nrtis-as-a-backbone-switched-from-a-stable-boosted-pi-regimen-132335https://curecurrent.com/trials/multi-level-determinants-of-starting-art-late-aim-2-132336https://curecurrent.com/trials/multi-level-determinants-of-starting-art-late-aim-3-132337https://curecurrent.com/trials/kaletra-isentress-treatment-evaluation-132338https://curecurrent.com/trials/diversion-to-treatment-for-injection-drug-users-arrested-for-possession-of-heroin-132339https://curecurrent.com/trials/reducing-drug-use-and-hiv-risk-in-drug-dependent-adults-arrested-for-prostitution-132340https://curecurrent.com/trials/evaluating-post-test-hiv-counseling-videos-for-teens-132341https://curecurrent.com/trials/a-theory-based-hiv-prevention-video-for-rapid-hiv-testing-a-randomized-trial-132342https://curecurrent.com/trials/frequency-and-clinical-significance-of-renal-and-bone-toxicity-in-hiv-infected-patients-132343https://curecurrent.com/trials/evaluating-factors-that-impact-loss-to-follow-up-among-postpartum-hiv-infected-women-in-mississippi-132344https://curecurrent.com/trials/a-clinical-trial-for-people-hiv-age-50-at-risk-for-heart-disease-132345https://curecurrent.com/trials/ever-tmc-mutation-as-marker-of-the-risk-of-cutaneous-carcinoma-in-immunosuppressed-patients-132346https://curecurrent.com/trials/evaluation-of-barriers-to-postpartum-care-in-hiv-infected-women-132347https://curecurrent.com/trials/enhancing-hiv-risk-reduction-among-indian-women-with-risky-husbands-132348https://curecurrent.com/trials/nurse-delivered-cell-phone-adherence-intervention-pick-it-up-132349https://curecurrent.com/trials/integrated-infectious-disease-capacity-building-evaluation-132350https://curecurrent.com/trials/an-educational-and-supportive-counseling-program-for-increasing-antiretroviral-use-and-adherence-in-people-with-hiv-132351https://curecurrent.com/trials/tenofovir-emtricitabine-efavirenz-and-atazanavir-pharmacokinetics-in-the-aging-hiv-infected-population-132352https://curecurrent.com/trials/bioavailability-study-of-a-dolutegravir-dispersible-tablet-and-effect-of-different-types-of-water-on-the-dispersible-tab-132353https://curecurrent.com/trials/atripla-to-raltegravir-switch-study-for-cns-toxicity-132354https://curecurrent.com/trials/vitamin-d-in-hiv-infected-patients-on-haart-132355https://curecurrent.com/trials/intermittent-art-in-primary-hiv-infection-132356https://curecurrent.com/trials/economic-clinical-and-quality-of-life-assessment-in-patients-on-antiretroviral-therapy-132357https://curecurrent.com/trials/efficacy-and-safety-of-sofosbuvir-plus-ribavirin-in-chronic-genotype-1-2-and-3-hepatitis-c-virus-hcv-and-human-immunodef-132358https://curecurrent.com/trials/empiric-therapy-of-helminth-co-infection-to-reduce-hiv-1-disease-progression-132359https://curecurrent.com/trials/switching-undetectables-to-selzentry-132360https://curecurrent.com/trials/immune-based-therapy-pilot-study-for-the-treatment-of-primary-hiv-infection-phi-imd-132361https://curecurrent.com/trials/safety-and-immunogenicity-of-13-valent-pneumococcal-conjugate-vaccine-13vpnc-in-hiv-infected-subjects-6-years-of-age-or-132362https://curecurrent.com/trials/switching-nevirapine-immediate-release-ir-based-regimen-to-nevirapine-extended-release-xr-based-regimen-in-human-immunod-132363https://curecurrent.com/trials/efavirenz-to-dolutegravir-switch-in-patients-with-cns-toxicity-132364https://curecurrent.com/trials/omega-3-fatty-acids-for-high-triglycerides-in-hiv-infected-patients-132365https://curecurrent.com/trials/changes-in-insulin-resistance-in-healthy-volunteers-on-stribild-medication-132366https://curecurrent.com/trials/a-safety-and-efficacy-study-of-amdoxovir-in-hiv-1-treatment-experienced-subjects-132367https://curecurrent.com/trials/follow-up-study-to-evaluate-a-non-surgical-device-for-adult-male-circumcision-for-screen-failure-subjects-132368https://curecurrent.com/trials/feasibility-study-of-prepex-device-when-performed-on-early-infants-children-male-population-by-physicians-132369https://curecurrent.com/trials/a-phase-4-cross-sectional-study-of-bone-mineral-density-in-hiv-1-infected-subjects-132370https://curecurrent.com/trials/treatment-effects-of-escitalopram-lexapro-on-generalized-anxiety-disorder-in-patients-with-hiv-and-aids-132371https://curecurrent.com/trials/epidemiology-of-papillomavirus-infection-hpv-on-infected-women-by-human-immunodeficience-virus-hiv-in-west-indies-and-fr-132372https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-efficacy-of-tmc435-along-with-pegylated-interferon-alpha-2a-pegasys-and-ri-132373https://curecurrent.com/trials/hiv-prevention-in-haitian-american-adolescents-132374https://curecurrent.com/trials/mupirocin-ointment-to-eliminate-nasal-carriage-of-staphylococcus-aureus-in-hiv-infection-132375https://curecurrent.com/trials/the-effect-of-anti-hiv-treatment-on-body-characteristics-of-hiv-infected-children-132376https://curecurrent.com/trials/evaluation-of-the-mbio-combined-syphilis-hiv-point-of-care-diagnostic-test-132377https://curecurrent.com/trials/hiv-patients-illness-perception-and-adherence-132378https://curecurrent.com/trials/study-targeting-affect-regulation-132379https://curecurrent.com/trials/stonewall-treatment-evaluation-project-132380https://curecurrent.com/trials/feasibility-of-a-stigma-reduction-intervention-for-human-immunodeficiency-virus-hiv-infected-women-132381https://curecurrent.com/trials/couples-in-context-an-rct-of-a-couples-based-hiv-prevention-intervention-132382https://curecurrent.com/trials/acceptability-of-pharmacologic-treatment-for-methamphetamine-dependence-among-msm-132383https://curecurrent.com/trials/early-versus-delayed-routine-hiv-testing-in-connecticut-jails-132384https://curecurrent.com/trials/when-to-start-anti-hiv-drugs-in-patients-with-opportunistic-infections-132385https://curecurrent.com/trials/early-versus-standard-start-of-anti-hiv-therapy-for-treatment-naive-adults-in-haiti-132386https://curecurrent.com/trials/suicidality-and-suicide-attempt-among-hiv-patients-on-efavirenz-containing-versus-efavirenz-free-antiretroviral-regimens-132387https://curecurrent.com/trials/assessing-the-impact-of-an-intervention-to-prevent-intimate-partner-violence-and-hiv-in-uganda-132388https://curecurrent.com/trials/boceprevir-in-hiv-hcv-coinfected-patients-who-have-failed-to-a-previous-therapy-with-peg-interferon-ribavirin-132389https://curecurrent.com/trials/chloroquine-for-reducing-immune-activation-in-hiv-infected-individuals-132390https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-etravirine-administered-in-combination-with-other-an-132391https://curecurrent.com/trials/prenatal-and-postnatal-studies-of-interventions-for-prevention-of-mother-to-child-transmission-132392https://curecurrent.com/trials/changes-in-lipids-and-safety-of-raltegravir-in-hiv-patients-with-hyperlipidemia-while-on-current-standard-therapy-132393https://curecurrent.com/trials/hiv-viral-load-monitoring-in-resource-poor-settings-132394https://curecurrent.com/trials/reducing-hiv-risk-among-episodic-substance-using-men-who-have-sex-with-men-sumsm-132395https://curecurrent.com/trials/topical-metronidazole-and-miconazole-co-formulated-vaginal-suppositories-for-preventing-vaginal-infections-in-hiv-serone-132396https://curecurrent.com/trials/efficacy-of-doxycycline-prophylaxis-to-reduce-syphilis-in-high-risk-hiv-positive-msm-132397https://curecurrent.com/trials/utility-of-urinary-beta2-microglobulin-as-an-early-marker-of-renal-dysfunction-in-vietnamese-hiv-infected-patients-132398https://curecurrent.com/trials/peginterferon-alpha-2b-and-ribavirin-to-treat-hepatitis-c-in-hiv-infected-patients-132399https://curecurrent.com/trials/dose-escalation-study-of-the-safety-tolerability-and-pharmacokinetics-of-bilr-355-bs-plus-low-dose-ritonavir-in-hiv-unin-132400https://curecurrent.com/trials/part-a-drug-interaction-study-of-sofosbuvir-and-antiretroviral-therapy-art-combinations-in-hiv-and-hepatitis-c-virus-hcv-132401https://curecurrent.com/trials/enhanced-hiv-prevention-in-couples-feasibility-study-3-132402https://curecurrent.com/trials/choices-teen-a-bundled-risk-reduction-intervention-for-juvenile-justice-females-132403https://curecurrent.com/trials/hiv-rapid-testing-counseling-in-sexually-transmitted-disease-std-clinics-in-the-u-s-132404https://curecurrent.com/trials/a-two-way-cross-over-pharmacokinetic-interaction-study-between-raltegravir-and-amlodipine-in-healthy-volunteers-132405https://curecurrent.com/trials/effects-of-tipranavir-ritonavir-on-the-pharmacokinetic-characteristics-of-triple-drug-nucleoside-and-non-nucleoside-reve-132406https://curecurrent.com/trials/qualitative-assessment-of-implementing-routine-rapid-hiv-testing-132407https://curecurrent.com/trials/epidermal-nerve-fiber-density-fat-and-mitochondrial-parameters-in-thai-hiv-patients-on-d4t-and-hiv-patients-132408https://curecurrent.com/trials/hiv-1-specific-immune-responses-in-thai-individuals-with-hiv-dementia-132409https://curecurrent.com/trials/establishing-normal-values-for-neuropsychological-testing-in-hiv-negative-thais-132410https://curecurrent.com/trials/nrti-sparing-pilot-study-132411https://curecurrent.com/trials/peripheral-reservoir-of-hiv-dna-in-monocytes-pivotal-to-cognition-in-hiv-132412https://curecurrent.com/trials/effects-of-cyp2b6-genetic-polymorphisms-on-efavirenz-pharmacokinetics-132413https://curecurrent.com/trials/tipranavir-dose-response-study-using-a-prototype-self-emulsifying-drug-delivery-system-sedds-formulation-in-treatment-na-132414https://curecurrent.com/trials/hiv-liver-regeneration-project-for-hiv-patients-with-cirrhosis-by-autologous-bone-marrow-transplantation-132415https://curecurrent.com/trials/validation-of-implementation-of-cervical-dysplasia-treatment-modalities-in-hiv-seropositive-women-132416https://curecurrent.com/trials/community-based-delivery-of-integrated-family-planning-hiv-testing-and-counseling-services-in-uganda-132417https://curecurrent.com/trials/clinical-trial-to-assess-the-effect-of-the-change-of-efavirenz-efv-for-lopinavir-ritonavir-lpv-r-in-lipoatrophy-in-hiv-i-132418https://curecurrent.com/trials/acceptability-of-depo-subq-provera-104-in-uniject-vs-intramuscular-depo-provera-among-hiv-women-providers-uganda-132419https://curecurrent.com/trials/non-virologic-methods-to-diagnose-treatment-eligibility-in-hiv-exposed-infants-132420https://curecurrent.com/trials/immune-reconstitution-to-measles-virus-of-hiv-infected-children-in-zambia-132421https://curecurrent.com/trials/reducing-sexual-risk-behaviors-and-improving-health-for-people-at-a-sexually-transmitted-infection-clinic-132422https://curecurrent.com/trials/infrared-coagulation-in-preventing-anal-cancer-in-patients-with-hiv-who-have-anal-neoplasia-132423https://curecurrent.com/trials/tipranavir-and-ritonavir-vs-saquinavir-and-ritonavir-used-with-two-nucleoside-reverse-transcriptase-inhibitors-in-single-132424https://curecurrent.com/trials/therapeutic-intensification-plus-immunomodulation-to-decrease-the-hiv-1-viral-reservoir-132425https://curecurrent.com/trials/computer-based-cognitive-behavioral-therapy-for-risky-behaviors-in-opioid-dependent-patients-132426https://curecurrent.com/trials/exploratory-study-of-tipranavir-and-ritonavir-in-multiple-protease-inhibitor-experienced-hiv-patients-132427https://curecurrent.com/trials/magnitude-of-the-antibody-response-to-and-safety-of-a-gbs-trivalent-vaccine-in-hiv-positive-and-hiv-negative-pregnant-wo-132428https://curecurrent.com/trials/visual-inspection-with-acetic-acid-compared-to-lugol-s-iodine-in-hiv-infected-women-132429https://curecurrent.com/trials/immune-response-to-hpv-vaccine-among-hiv-1-infected-subjects-in-brazil-132430https://curecurrent.com/trials/the-peercare-study-peer-community-based-assistant-in-retention-132431https://curecurrent.com/trials/concentrations-of-maraviroc-in-the-semen-of-hiv-infected-men-132432https://curecurrent.com/trials/raltegravir-and-darunavir-antiretroviral-in-antiretroviral-naive-patients-132433https://curecurrent.com/trials/pilot-study-to-assess-the-efficacy-of-and-tolerance-to-a-quadruple-therapy-to-treat-hiv-hcv-coinfected-patients-previous-132434https://curecurrent.com/trials/study-to-determine-the-antiviral-activity-and-safety-of-alovudine-in-nucleoside-experienced-hiv-infected-subjects-experi-132435https://curecurrent.com/trials/comparative-study-of-three-nnrti-sparing-haart-regimens-132436https://curecurrent.com/trials/maraviroc-plus-darunavir-ritonavir-for-treatment-na-ve-patients-infected-with-r5-tropic-hiv-1-132437https://curecurrent.com/trials/pneumococcal-conjugate-vaccine-pcv-in-hiv-infected-children-132438https://curecurrent.com/trials/acupuncture-and-relaxation-response-for-gi-symptoms-and-hiv-medication-adherence-132439https://curecurrent.com/trials/effect-of-steady-state-tpv-r-on-intracellular-concentrations-of-zidovudine-and-carbovir-for-patients-with-hiv-132440https://curecurrent.com/trials/microparticles-vector-of-genetic-information-during-hiv-infection-132441https://curecurrent.com/trials/sirolimus-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132442https://curecurrent.com/trials/bioequivalence-study-of-individual-atazanavir-and-cobicistat-compared-with-atazanavir-in-fixed-dose-combination-with-cob-132443https://curecurrent.com/trials/alcohol-suicide-and-hiv-prevention-for-teens-in-mental-health-treatment-132444https://curecurrent.com/trials/anti-hiv-treatment-interruptions-in-hiv-infected-adults-in-south-africa-132445https://curecurrent.com/trials/pilot-feasibility-trial-of-the-family-strengthening-intervention-in-rwanda-fsi-r-132446https://curecurrent.com/trials/atazavanir-ritonavir-based-haart-in-children-132447https://curecurrent.com/trials/a-study-to-assess-the-long-term-safety-and-tolerability-of-tmc114-rtv-in-hiv-1-infected-participants-after-rolling-over-132448https://curecurrent.com/trials/evaluation-of-atazanavir-substitution-intervention-easi-study-132449https://curecurrent.com/trials/hiv-hcv-coinfection-impact-of-immune-dysfunction-132450https://curecurrent.com/trials/directly-observed-therapy-for-community-released-hiv-prisoners-132451https://curecurrent.com/trials/anti-retrovirals-for-kaposi-s-sarcoma-132452https://curecurrent.com/trials/study-on-the-impact-of-triptolide-woldifiion-on-hiv-1-reservoir-in-acute-hiv-1-infection-132453https://curecurrent.com/trials/cotrimoxazole-prophylaxis-in-severely-malnourished-children-132454https://curecurrent.com/trials/the-effect-of-vitamin-d-supplementation-on-hiv-associated-platelet-hyperreactivity-132455https://curecurrent.com/trials/effects-of-facility-based-mother-support-groups-on-prevention-of-mother-to-child-transmission-outcomes-in-zimbabwe-132456https://curecurrent.com/trials/etravirine-pharmacokinetics-and-hiv-viral-load-in-breast-milk-and-plasma-132457https://curecurrent.com/trials/effects-of-low-dose-maintenance-peg-interferon-alfa-2b-therapy-versus-supportive-care-in-patients-with-cirrhotic-hepatit-132458https://curecurrent.com/trials/concentrations-of-raltegravir-in-the-semen-of-hiv-infected-men-132459https://curecurrent.com/trials/mesalamine-to-reduce-t-cell-activation-in-hiv-infection-132460https://curecurrent.com/trials/effects-of-anti-hiv-drugs-on-the-hepatitis-c-virus-hcv-in-adults-infected-with-both-hcv-and-hiv-132461https://curecurrent.com/trials/pharmaco-epidemiological-description-of-the-population-treated-with-aptivus-under-market-conditions-safety-efficacy-132462https://curecurrent.com/trials/preventing-hiv-aids-in-drug-abusing-youth-132463https://curecurrent.com/trials/a-rollover-study-for-subjects-discontinuing-from-uk-453-061-studies-for-the-treatment-of-hiv-1-132464https://curecurrent.com/trials/targeted-screening-of-at-risk-adults-for-acute-hiv-1-infection-132465https://curecurrent.com/trials/study-to-explore-the-effect-of-mefloquine-in-participants-with-progressive-multifocal-leukoencephalopathy-pml-132466https://curecurrent.com/trials/mfangano-island-healthy-networks-impact-study-132467https://curecurrent.com/trials/efficacy-and-safety-of-varenicline-among-hiv-infected-patients-132468https://curecurrent.com/trials/study-to-evaluate-the-activity-and-tolerability-of-lopinavir-ritonavir-and-lamivudine-bitherapy-in-hiv-patients-with-vir-132469https://curecurrent.com/trials/risk-reduction-for-urban-substance-using-men-who-have-sex-with-men-msm-132470https://curecurrent.com/trials/interferon-alfa-in-treating-children-with-hiv-related-cancer-132471https://curecurrent.com/trials/an-adherence-tool-to-manage-narcotic-addicted-hiv-patients-132472https://curecurrent.com/trials/bioavailability-of-2-different-nevirapine-extended-release-formulations-compared-to-viramune-in-hiv-1-infected-subjects-132473https://curecurrent.com/trials/treatment-with-nutritional-eating-plan-and-dietary-fibers-in-adult-patients-with-hiv-aids-132474https://curecurrent.com/trials/a-study-to-assess-the-relative-bioavailability-of-new-tablet-formulations-of-gsk1265744-in-healthy-adult-subjects-132475https://curecurrent.com/trials/impact-of-switching-to-nnrti-based-therapy-on-the-quality-of-life-of-hiv-infected-patients-with-virological-suppression-132476https://curecurrent.com/trials/observational-study-with-antiretroviral-treated-patients-switching-to-nevirapine-plus-two-nucleoside-reverse-transcripta-132477https://curecurrent.com/trials/antiretroviral-activity-and-pharmacokinetics-of-deferiprone-in-healthy-volunteers-and-asymptomatic-hiv-infected-subjects-132478https://curecurrent.com/trials/long-term-study-in-patients-under-anti-retroviral-combination-therapy-switching-to-viramune-132479https://curecurrent.com/trials/observational-study-in-patients-with-hiv-infection-type-1-after-switching-to-a-viramune-containing-therapy-regimen-132480https://curecurrent.com/trials/clinical-and-therapeutic-evaluation-of-the-infection-by-hiv-aids-132481https://curecurrent.com/trials/comparing-blood-vessel-endothelial-function-in-hiv-infected-people-and-matched-hiv-uninfected-people-132482https://curecurrent.com/trials/botswana-vitamin-d-supplementation-study-in-hiv-aids-132483https://curecurrent.com/trials/study-to-determine-the-effects-of-nevirapine-viramune-on-the-steady-state-pharmacokinetics-of-rifabutin-mycobutin-in-hiv-132484https://curecurrent.com/trials/clotrimazole-vs-mycelex-in-patients-with-human-insufficiency-virus-hiv-infection-for-the-treatment-of-oropharyngeal-cand-132485https://curecurrent.com/trials/study-of-nevirapine-and-prednisone-to-determine-the-safety-and-effectiveness-in-preventing-nevirapine-associated-rash-in-132486https://curecurrent.com/trials/investigation-of-the-potential-pharmacokinetic-interaction-between-nevirapine-viramune-and-ethinyl-estradiol-norethindro-132487https://curecurrent.com/trials/investigation-of-the-potential-pharmacokinetic-interaction-between-nevirapine-abacavir-and-amprenavir-in-hiv-1-infected-132488https://curecurrent.com/trials/efficacy-of-nevirapine-compared-to-zdv-3tc-administered-in-labor-and-again-at-postdelivery-in-hiv-positive-women-132489https://curecurrent.com/trials/pharmacokinetic-interaction-between-nevirapine-and-saquinavir-sgc-in-hiv-1-infected-patients-132490https://curecurrent.com/trials/effects-of-nevirapine-on-the-steady-state-pharmacokinetics-of-fluconazole-in-hiv-positive-patients-132491https://curecurrent.com/trials/evaluation-of-a-blood-test-to-measure-immune-function-in-hiv-positive-people-compared-with-hiv-negative-people-132492https://curecurrent.com/trials/development-and-evaluation-of-an-hiv-std-and-pregnancy-prevention-program-for-middle-school-students-132493https://curecurrent.com/trials/impact-evaluation-study-of-the-faithful-house-programme-on-violence-reduction-in-families-132494https://curecurrent.com/trials/phase-ii-randomised-controlled-trial-of-memory-work-therapy-at-pasada-tanzania-132495https://curecurrent.com/trials/randomized-evaluation-of-strategic-intervention-in-multidrug-resistant-patients-with-tipranavir-resist-132496https://curecurrent.com/trials/tipranavir-ritonavir-vs-genotypically-defined-protease-inhibitor-ritonavir-in-hiv-patients-resist-2-132497https://curecurrent.com/trials/non-interventional-observational-study-with-viramune-nevirapine-and-various-drug-combinations-in-the-antiretroviral-comb-132498https://curecurrent.com/trials/spring-safety-efficacy-pharmacokinetics-of-tipranavir-r-in-race-gender-hiv-patients-randomized-to-tdm-or-soc-132499https://curecurrent.com/trials/a-study-of-tmc278-in-human-immunodeficiency-virus-type-1-infected-patients-who-are-not-treated-with-antiretroviral-medic-132500https://curecurrent.com/trials/evaluation-of-a-lopinavir-ritonavir-monotherapy-vs-a-triple-therapy-as-maintenance-regimens-in-hiv-1-infected-patients-132501https://curecurrent.com/trials/an-open-label-trial-of-tmc114-rtv-in-hiv-1-infected-treatment-experienced-subjects-132502https://curecurrent.com/trials/tmc125-c206-a-phase-iii-study-to-investigate-the-efficacy-tolerability-and-safety-of-tmc125-as-part-of-an-antiretroviral-132503https://curecurrent.com/trials/a-feasibility-study-to-assess-tenofovir-and-maraviroc-protection-against-hiv-1-in-cervical-and-vaginal-explants-132504https://curecurrent.com/trials/the-rilpivirine-cerebrospinal-fluid-csf-study-132505https://curecurrent.com/trials/trial-to-assess-the-lipid-lowering-effect-of-adding-tenofovir-emtricitabine-co-formulation-vs-placebo-to-hiv-1-infected-132506https://curecurrent.com/trials/study-to-evaluate-the-effect-of-gsk1265744-on-cardiac-conduction-132507https://curecurrent.com/trials/effects-of-probiotics-on-microbial-translocation-and-immune-activation-markers-in-hiv-positive-patients-on-combined-anti-132508https://curecurrent.com/trials/web-based-middle-school-hiv-prevention-curricula-aspiring-for-reach-and-impact-132509https://curecurrent.com/trials/zinc-supplementation-effect-on-immune-recovery-in-hiv-patients-132510https://curecurrent.com/trials/effectiveness-of-armodafinil-for-treating-fatigue-in-adults-with-hiv-aids-132511https://curecurrent.com/trials/effect-of-omega-3-fatty-acid-supplementation-on-hypertriglyceridemia-in-hiv-infected-children-132512https://curecurrent.com/trials/men-of-african-american-legacy-empowering-self-132513https://curecurrent.com/trials/outcomes-for-antiretroviral-therapy-patients-receiving-palliative-care-132514https://curecurrent.com/trials/female-upper-genital-tract-in-hiv-infected-women-132515https://curecurrent.com/trials/study-to-evaluate-the-drug-interaction-between-dolutegravir-dtg-and-daclatasvir-dcv-in-healthy-adult-subjects-132516https://curecurrent.com/trials/effectiveness-of-opiate-replacement-therapy-administered-prior-to-release-from-a-correctional-facility-1-132517https://curecurrent.com/trials/efficacy-study-of-different-laboratory-management-strategies-and-drug-regimens-in-hiv-infected-children-in-africa-132518https://curecurrent.com/trials/vitamin-d-supplementation-and-cd4-count-in-hiv-infected-children-132519https://curecurrent.com/trials/tipranavir-ritonavir-low-dose-pharmacokinetics-in-treatment-naive-patients-132520https://curecurrent.com/trials/prevention-for-positives-an-rct-among-vietnamese-hiv-positive-idu-132521https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-stribild-versus-atripla-in-human-immunodeficiency-virus-type-1-hiv-1-infected-antire-132522https://curecurrent.com/trials/increasing-hiv-testing-in-urban-emergency-departments-via-mobile-technology-132523https://curecurrent.com/trials/an-open-label-blinded-assessor-trial-comparing-odor-levels-due-to-different-hygiene-methods-with-prepextm-132524https://curecurrent.com/trials/hcv-evolution-in-hiv-hcv-genotype-1-coinfected-patients-treated-with-fosamprenavir-132525https://curecurrent.com/trials/cns-central-nervous-system-viral-dynamics-and-cellular-immunity-during-aids-132526https://curecurrent.com/trials/effect-of-dolutegravir-on-metformin-pharmacokinetics-in-healthy-adult-subjects-132527https://curecurrent.com/trials/cohort-field-study-to-assess-the-safety-and-efficacy-of-the-prepex-device-for-non-surgical-circumcision-when-performed-b-132528https://curecurrent.com/trials/juvenile-detention-to-community-life-132529https://curecurrent.com/trials/genetic-predictors-of-variability-in-the-drug-drug-interaction-between-darunavir-ritonavir-and-pravastatin-132530https://curecurrent.com/trials/multi-vitamins-haart-and-hiv-aids-in-uganda-132531https://curecurrent.com/trials/an-observational-study-to-evaluate-tolerability-of-prezista-or-intelence-in-hiv-1-infected-patients-132532https://curecurrent.com/trials/euroneut41-safety-immunogenicity-of-immunisations-with-hiv-vaccine-132533https://curecurrent.com/trials/safety-immunogenicity-of-immunisations-with-en41-ugr7c-hiv-vaccine-132534https://curecurrent.com/trials/the-cognaive-study-assessing-changes-in-neurocognitive-function-in-treatment-na-ve-hiv-1-positive-subjects-132535https://curecurrent.com/trials/observational-non-interventional-study-with-viramune-in-combination-with-truvada-in-hiv-infected-patients-132536https://curecurrent.com/trials/pharmacology-of-antimalarial-therapy-with-or-without-antiretroviral-therapy-132537https://curecurrent.com/trials/a-study-to-investigate-the-recovery-excretion-and-pharmacokinetics-of-14c-gsk2248761-administered-as-an-oral-suspension-132538https://curecurrent.com/trials/evaluating-host-and-viral-factors-among-hiv-infected-former-commercial-blood-donors-in-fuyang-anhui-province-china-132539https://curecurrent.com/trials/collection-of-blood-samples-from-hiv-infected-people-132540https://curecurrent.com/trials/impaact-p1073-study-of-iris-for-infants-and-children-initiating-haart-at-int-l-sites-132541https://curecurrent.com/trials/acipimox-to-improve-hyperlipidemia-and-insulin-sensitivity-associated-with-hiv-132542https://curecurrent.com/trials/safety-and-antiviral-activity-of-tpv-in-hcv-and-or-hbv-hiv-coinfected-patients-tdm-randomised-pilot-evaluation-132543https://curecurrent.com/trials/comparison-of-tpv-r-to-drv-r-in-triple-class-experienced-patient-with-resistance-to-1-pi-132544https://curecurrent.com/trials/rifabutin-based-therapy-for-the-eradication-of-staphylococcus-aureus-colonization-in-hiv-infected-adults-132545https://curecurrent.com/trials/combination-chemotherapy-and-rituximab-in-treating-patients-with-hiv-associated-stage-i-stage-ii-stage-iii-or-stage-iv-n-132546https://curecurrent.com/trials/safety-and-acceptability-of-the-prepex-device-for-male-circumcision-in-zambia-132547https://curecurrent.com/trials/pentoxifylline-and-combination-antiretroviral-therapy-to-improve-blood-vessel-function-in-hiv-infected-people-132548https://curecurrent.com/trials/pharmacokinetics-and-safety-study-of-tipranavir-in-combination-with-low-dose-ritonavir-in-human-immunodeficiency-virus-h-132549https://curecurrent.com/trials/positively-smoke-free-on-the-web-psfw-for-smokers-living-with-hiv-132550https://curecurrent.com/trials/non-enrolment-and-non-adherence-to-hiv-care-in-a-community-based-program-rakai-uganda-132551https://curecurrent.com/trials/an-exploratory-rectal-safety-study-of-three-tenofovir-gel-formulations-132552https://curecurrent.com/trials/dcvax-plus-poly-iclc-in-healthy-volunteers-132553https://curecurrent.com/trials/disulfiram-interactions-with-hiv-medications-clinical-implications-132554https://curecurrent.com/trials/interaction-of-buprenorphine-with-hiv-medications-and-tuberculosis-medications-132555https://curecurrent.com/trials/interaction-of-alcohol-and-highly-active-antiretroviral-therapy-haart-in-hiv-aids-and-hiv-aids-with-hepatitis-c-virus-hc-132556https://curecurrent.com/trials/dose-response-study-of-ibalizumab-monoclonal-antibody-plus-optimized-background-regimen-in-patients-with-hiv-1-132557https://curecurrent.com/trials/engaging-informal-health-care-providers-on-case-detection-and-treatment-initiation-rates-for-tb-and-hiv-in-rural-malawi-132558https://curecurrent.com/trials/safety-and-immunogenicity-study-of-three-candidate-hiv-1-vaccines-administered-in-combination-to-healthy-hiv-1-uninfecte-132559https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-efavirenz-in-hiv-infected-children-132560https://curecurrent.com/trials/a-12-week-study-comparing-pitavastatin-4-mg-vs-pravastatin-40-mg-in-hiv-infected-subjects-132561https://curecurrent.com/trials/serological-response-to-antipneumococcal-vaccination-and-impact-on-streptococcus-pneumoniae-nasal-carriage-in-hiv-adults-132562https://curecurrent.com/trials/immunogenicity-of-inactivated-swine-h1n1-vaccine-in-hiv-infected-children-the-miami-cohort-study-132563https://curecurrent.com/trials/immune-responses-to-pneumococcal-vaccination-among-hiv-infected-subjects-132564https://curecurrent.com/trials/clinical-trial-of-cns-targeted-haart-cit2-132565https://curecurrent.com/trials/the-natural-history-and-treatment-of-acute-hepatitis-c-virus-hcv-in-hiv-positive-individuals-132566https://curecurrent.com/trials/immunosuppression-in-hiv-infected-patients-with-tuberculosis-in-ethiopia-132567https://curecurrent.com/trials/a-safety-study-to-evaluate-the-antiviral-activity-of-darunavir-in-combination-with-ritonavir-in-hiv-1-infected-children-132568https://curecurrent.com/trials/differences-in-response-to-the-flu-vaccine-among-adults-with-hiv-and-without-hiv-in-uganda-132569https://curecurrent.com/trials/quality-of-life-in-children-with-hiv-infection-132570https://curecurrent.com/trials/hiv-cohort-study-at-johns-hopkins-university-university-of-north-carolina-at-chapel-hill-and-vanderbilt-university-132571https://curecurrent.com/trials/a-randomized-study-to-assess-the-relative-bioavailability-of-new-formulations-of-gsk1265744-long-acting-parental-lap-in-132572https://curecurrent.com/trials/grace-a-study-to-compare-the-effectiveness-safety-and-tolerability-of-prezista-darunavir-ritonavir-by-gender-and-race-wh-132573https://curecurrent.com/trials/effects-of-two-anti-hiv-drug-regimens-on-quality-of-life-and-health-care-use-among-smart-study-participants-132574https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-effectiveness-of-three-anti-hiv-drug-regimens-in-hiv-infected-patients-who-have-never-132575https://curecurrent.com/trials/the-effect-of-anti-hiv-therapy-on-fat-metabolism-in-hiv-positive-patients-132576https://curecurrent.com/trials/effects-of-two-anti-hiv-drug-regimens-on-hiv-transmission-risk-behavior-among-smart-study-participants-132577https://curecurrent.com/trials/effects-of-anti-hiv-therapy-on-nervous-system-function-132578https://curecurrent.com/trials/a-study-of-anal-cancer-development-in-hiv-infected-people-132579https://curecurrent.com/trials/raltegravir-use-as-nonoccupational-postexposure-prophylaxis-npep-in-men-who-have-sex-with-men-132580https://curecurrent.com/trials/a-study-of-the-long-term-outcomes-of-hiv-positive-patients-132581https://curecurrent.com/trials/oral-triple-combination-antiviral-drug-therapy-for-treatment-of-influenza-a-in-immunocompromised-subjects-132582https://curecurrent.com/trials/body-image-in-youth-with-hiv-132583https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-infant-peri-exposure-prophylaxis-with-lopinavir-ritonavir-versus-lamivudine-to-prev-132584https://curecurrent.com/trials/men-who-have-sex-with-men-msm-neurocog-1-2-study-132585https://curecurrent.com/trials/tmc114-c226-an-early-access-program-to-evaluate-the-long-term-safety-and-tolerability-of-tmc114-combined-with-a-low-dose-132586https://curecurrent.com/trials/the-effect-of-hyperbilirubinemia-on-cv-disease-neurocog-function-and-renal-function-132587https://curecurrent.com/trials/discontinuation-of-trimethoprim-sulfamethoxazole-prophylaxis-in-adults-on-antiretroviral-therapy-in-kenya-132588https://curecurrent.com/trials/safety-and-immunogenicity-study-of-influenza-vaccines-in-hiv-infected-and-hiv-uninfected-pregnant-women-in-western-kenya-132589https://curecurrent.com/trials/examining-factors-that-may-influence-resistance-to-hiv-1-infection-132590https://curecurrent.com/trials/study-of-dolutegravir-dtg-on-pk-of-cenicriviroc-cvc-and-cvc-on-pk-of-dtg-on-a-single-dose-of-midazolam-132591https://curecurrent.com/trials/project-unity-hiv-risk-reduction-and-vaccine-education-interventions-132592https://curecurrent.com/trials/valacyclovir-vs-acyclovir-as-hsv-2-suppressive-therapy-effect-on-plasma-hiv-1-levels-among-hiv-1-hsv-2-co-infected-perso-132593https://curecurrent.com/trials/home-assessment-and-initiation-of-antiretroviral-therapy-for-hiv-in-malawi-132594https://curecurrent.com/trials/verxve-study-on-efficacy-and-safety-of-nevirapine-xr-in-comparison-to-nevirapine-ir-with-truvada-in-naive-hiv-patients-132595https://curecurrent.com/trials/observational-non-interventional-study-anwendungsbeobachtung-with-aptivus-tipranavir-in-hiv-infected-patients-132596https://curecurrent.com/trials/europe-africa-research-network-for-evaluation-of-second-line-therapy-132597https://curecurrent.com/trials/effects-of-motivational-interviewing-on-risky-injecting-practices-among-injecting-drug-users-idus-132598https://curecurrent.com/trials/tb-iris-nsaid-cox-2-inhibitor-prevention-trial-132599https://curecurrent.com/trials/tmc207-tidp13-c117-interaction-study-in-human-immunodeficiency-virus-type-1-hiv-1-infected-patients-with-nevirapine-nvp-132600https://curecurrent.com/trials/efficacy-and-safety-of-two-pharmacologic-strategies-on-neurocognitive-impairment-in-hiv-infection-the-triant-te-study-132601https://curecurrent.com/trials/clinical-outcomes-of-cryptococcal-meningitis-among-hiv-infected-patients-in-the-era-of-antiretroviral-therapy-132602https://curecurrent.com/trials/study-of-recovery-of-intestinal-cd4-and-th17-t-cells-in-hiv-infected-individuals-on-short-term-antiretroviral-therapy-132603https://curecurrent.com/trials/immunization-with-hiv-1-peptides-in-adjuvant-for-treatment-of-patients-with-chronic-hiv-infection-132604https://curecurrent.com/trials/an-efficacy-and-safety-trial-of-serostim-in-the-maintenance-of-the-treatment-effect-obtained-during-the-study-of-serosti-132605https://curecurrent.com/trials/safety-and-efficacy-trial-of-serostim-in-the-treatment-of-subjects-with-human-immunodeficiency-virus-associated-adipose-132606https://curecurrent.com/trials/aripiprazole-treatment-for-methamphetamine-dependence-among-high-risk-individuals-132607https://curecurrent.com/trials/comparison-of-liquid-kaletra-and-low-dose-kaletra-tablets-132608https://curecurrent.com/trials/a-post-marketing-surveillance-study-assessing-the-long-term-efficacy-and-safety-of-aptivus-co-administered-with-low-dose-132609https://curecurrent.com/trials/co-receptor-tropism-determination-of-hiv-1-subtype-a-spread-in-the-russian-federation-using-v3-based-genotyping-tools-132610https://curecurrent.com/trials/penta15-pharmacokinetic-study-of-once-versus-twice-daily-abacavir-in-hiv-1-infected-children-aged-3-to-36-months-132611https://curecurrent.com/trials/evaluation-of-alternative-antimalarial-drugs-for-malaria-in-pregnancy-132612https://curecurrent.com/trials/influence-of-atorvastatin-on-viral-replication-during-antiretroviral-treatment-interruption-132613https://curecurrent.com/trials/long-term-effects-of-highly-active-anti-retroviral-therapy-on-hiv-infected-children-132614https://curecurrent.com/trials/effects-of-highly-active-anti-retroviral-therapy-on-cardiovascular-health-in-infants-of-hiv-infected-mothers-132615https://curecurrent.com/trials/a-study-to-evaluate-safety-and-immunogenicity-of-aeras-402-132616https://curecurrent.com/trials/a-phase-i-study-to-evaluate-safety-and-immunogenicity-of-aeras-404-administered-in-adults-132617https://curecurrent.com/trials/fanconi-syndrome-due-to-arvs-in-hiv-infected-persons-132618https://curecurrent.com/trials/safety-study-of-once-a-day-art-and-opiate-substitute-132619https://curecurrent.com/trials/project-power-an-hiv-risk-reduction-intervention-for-black-men-who-have-sex-with-men-and-women-bmsm-w-132620https://curecurrent.com/trials/innate-immunity-in-hiv-positive-patients-co-infected-with-hepatitis-c-virus-hcv-or-hepatitis-b-virus-hbv-132621https://curecurrent.com/trials/extended-safety-study-of-tenofovir-disoproxil-fumarate-tdf-among-hiv-1-negative-men-132622https://curecurrent.com/trials/extended-infant-post-exposure-prophylaxis-with-antiretrovirals-to-reduce-postnatal-hiv-transmission-132623https://curecurrent.com/trials/pms-assessing-the-long-term-efficacy-and-safety-of-nevirapine-therapy-combined-with-other-arv-drugs-in-hiv-1-positive-pa-132624https://curecurrent.com/trials/rollover-trial-safety-and-tolerability-of-combination-tipranavir-and-ritonavir-use-in-hiv-1-infected-subjects-132625https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-and-cervicovaginal-lavage-of-combined-oral-contraceptives-and-raltegravir-132626https://curecurrent.com/trials/familias-unidas-preventing-drug-abuse-and-hiv-in-hispanic-first-offenders-132627https://curecurrent.com/trials/immunogenicity-of-three-hiv-gtu-multihiv-dna-immunisations-administered-via-intramuscular-intradermal-and-transcutaneous-132628https://curecurrent.com/trials/combivir-and-maraviroc-in-antiretroviral-naive-subjects-in-russia-132629https://curecurrent.com/trials/an-evidence-based-smoking-cessation-program-for-persons-living-with-hiv-aids-project-legacy-132630https://curecurrent.com/trials/evaluating-the-pharmacokinetics-of-400-mg-oral-dose-of-raltegravir-in-hiv-infected-pre-menopausal-women-132631https://curecurrent.com/trials/the-multimedia-hiv-sti-prevention-for-drug-involved-female-offenders-132632https://curecurrent.com/trials/hiv-prevention-for-injecting-drug-users-in-kazakhstan-132633https://curecurrent.com/trials/dendritic-cell-vaccine-in-hiv-1-infection-132634https://curecurrent.com/trials/does-provision-of-point-of-care-cd4-technology-and-early-knowledge-of-cd4-levels-affect-early-initiation-and-retention-o-132635https://curecurrent.com/trials/safety-and-effect-of-the-hdac-inhibitor-panobinostat-on-hiv-1-expression-in-patients-on-suppressive-haart-132636https://curecurrent.com/trials/violence-and-hiv-risk-among-women-132637https://curecurrent.com/trials/a-phase-i-randomized-placebo-controlled-double-blind-study-to-evaluate-safety-and-immunogenicity-of-aeras-404-administer-132638https://curecurrent.com/trials/prevention-of-early-mortality-by-presumptive-tuberculosis-tb-treatment-132639https://curecurrent.com/trials/clinical-study-to-evaluate-the-efficacy-and-safety-of-lopinavir-ritonavir-monotherapy-versus-darunavir-ritonavir-monothe-132640https://curecurrent.com/trials/early-versus-delayed-pneumococcal-vaccination-in-hiv-132641https://curecurrent.com/trials/hydroxychloroquine-for-discordant-cd4-responders-on-highly-active-antiretroviral-therapy-haart-132642https://curecurrent.com/trials/a-study-of-amd11070-in-hiv-infected-patients-carrying-x4-tropic-virus-132643https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-repeat-dose-administration-of-long-acting-gsk1265-132644https://curecurrent.com/trials/tmc114-tidp3-c176-a-study-in-healthy-volunteers-investigating-the-bioequivalence-between-two-commercially-available-400-132645https://curecurrent.com/trials/optimisation-of-primary-hiv1-infection-treatment-anrs-147-optiprim-132646https://curecurrent.com/trials/study-of-anti-r-huepo-associated-pure-red-cell-aplasia-prca-treatment-132647https://curecurrent.com/trials/na-ve-hiv-poc-monotherapy-trial-132648https://curecurrent.com/trials/nevirapine-vs-atazanavir-boosted-with-ritonavir-on-a-background-of-truvada-in-human-immunodeficiency-virus-hiv-infected-132649https://curecurrent.com/trials/effect-of-carbamazepine-on-dolutegravir-pharmacokinetics-in-healthy-adult-subjects-132650https://curecurrent.com/trials/effectiveness-of-a-risk-reduction-program-in-preventing-the-transmission-of-hiv-and-sexually-transmitted-diseases-in-afr-132651https://curecurrent.com/trials/nevirapine-or-atazanavir-ritonavir-given-with-emtricitabine-tenofovir-in-human-immunodeficiency-virus-hiv-1-infected-tre-132652https://curecurrent.com/trials/a-study-of-different-doses-of-uk-453-061-plus-truvada-compared-to-efavirenz-plus-truvada-in-patients-who-have-not-been-p-132653https://curecurrent.com/trials/a-case-management-intervention-to-prevent-er-visits-in-hiv-infected-persons-132654https://curecurrent.com/trials/safety-and-metabolic-study-of-highly-active-antiretroviral-therapy-haart-in-malnourished-children-with-hiv-132655https://curecurrent.com/trials/study-of-protease-inhibitor-regimen-switch-in-hiv-1-infected-patients-with-undetectable-viral-load-to-prove-the-non-infe-132656https://curecurrent.com/trials/promoting-male-involvement-to-improve-prevention-of-mother-to-child-transmission-pmtct-uptake-and-reduce-antenatal-infec-132657https://curecurrent.com/trials/comparison-of-hiv-testing-algorithms-132658https://curecurrent.com/trials/safety-study-of-mva-smallpox-vaccine-in-hiv-positive-subjects-who-are-vaccinia-naive-132659https://curecurrent.com/trials/kidney-and-liver-transplantation-in-people-with-hiv-132660https://curecurrent.com/trials/ipv-in-moderate-to-severe-chronic-malnourished-9-12-month-old-children-in-karachi-132661https://curecurrent.com/trials/rhiv-a-pilot-study-refractory-or-intolerant-to-highly-active-antiretroviral-therapy-haart-132662https://curecurrent.com/trials/the-once-a-day-protease-inhibitor-regimens-132663https://curecurrent.com/trials/a-dose-escalation-study-of-tenofovir-alafenamide-in-treatment-naive-patients-132664https://curecurrent.com/trials/immunotherapy-with-vacc-c5-with-adjuvant-gm-csf-or-alhydrogel-in-hiv-1-infected-subjects-on-art-132665https://curecurrent.com/trials/shaping-the-health-of-adolescents-in-zimbabwe-132666https://curecurrent.com/trials/an-expanded-access-study-of-oral-liquid-efavirenz-in-the-treatment-of-children-with-hiv-infection-canada-132667https://curecurrent.com/trials/an-expanded-access-study-of-oral-liquid-efavirenz-in-the-treatment-of-children-with-hiv-infection-132668https://curecurrent.com/trials/effects-of-short-term-growth-hormone-in-hiv-infected-patients-132669https://curecurrent.com/trials/a-study-of-physical-and-metabolic-abnormalities-in-hiv-infected-and-uninfected-children-and-youth-132670https://curecurrent.com/trials/hiv-prevention-preparedness-study-in-russia-china-and-india-132671https://curecurrent.com/trials/improving-treatment-adherence-in-hiv-infected-individuals-132672https://curecurrent.com/trials/a-study-to-explore-reconstitution-of-immunity-in-patients-with-advanced-hiv-1-infection-132673https://curecurrent.com/trials/effects-of-switching-efavirenz-to-raltegravir-on-vascular-function-and-bone-markers-in-hiv-infected-patients-132674https://curecurrent.com/trials/raltegravir-switch-study-effects-on-endothelial-recovery-132675https://curecurrent.com/trials/s-t-a-r-s-sistas-talking-about-real-solutions-132676https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-study-of-th9507-a-growth-hormone-releasing-factor-analog-in-hiv-positive-patients-132677https://curecurrent.com/trials/evaluating-rewards-based-adherence-and-electronic-medication-monitoring-in-hiv-positive-adolescents-132678https://curecurrent.com/trials/effectiveness-of-hiv-risk-reduction-program-among-african-american-men-132679https://curecurrent.com/trials/effectiveness-of-community-level-behavioral-and-biomedical-interventions-for-reducing-hiv-stis-in-men-in-peru-132680https://curecurrent.com/trials/effectiveness-of-hiv-sexually-transmitted-infection-training-for-physicians-in-china-132681https://curecurrent.com/trials/prospective-evaluation-of-etravirine-for-hiv-infected-patients-in-need-of-lipid-lowering-drugs-132682https://curecurrent.com/trials/community-mobilization-mobile-testing-same-day-results-and-post-test-support-for-hiv-in-sub-saharan-africa-and-thailand-132683https://curecurrent.com/trials/hiv-counseling-and-testing-and-linkage-to-care-in-uganda-132684https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-study-of-tenofovir-1-gel-132685https://curecurrent.com/trials/case-management-alternatives-for-african-american-women-at-high-risk-for-hiv-132686https://curecurrent.com/trials/gud-clinical-and-virologic-response-to-acyclovir-in-hiv-negative-african-women-132687https://curecurrent.com/trials/efficacy-of-ptx-ifn-alpha-rbv-on-hepatitis-c-virus-coinfected-hiv-patients-132688https://curecurrent.com/trials/immunogenicity-and-safety-of-trivalent-influenza-vaccine-in-non-pregnant-hiv-infected-women-132689https://curecurrent.com/trials/novel-therapy-for-glucose-intolerance-in-hiv-disease-132690https://curecurrent.com/trials/cognitive-stimulation-program-in-aids-132691https://curecurrent.com/trials/promoting-uptake-and-retention-of-option-b-in-malawi-132692https://curecurrent.com/trials/effect-of-dha-on-lipid-and-carbohydrate-metabolism-alterations-and-body-fat-distribution-in-hiv-patients-under-haart-132693https://curecurrent.com/trials/chloroquine-as-a-modulator-of-t-cell-immune-activation-132694https://curecurrent.com/trials/integrating-family-planning-services-into-hiv-care-and-treatment-in-nyanza-province-kenya-132695https://curecurrent.com/trials/antiretroviral-therapy-and-extreme-weight-132696https://curecurrent.com/trials/examining-the-incidence-of-oral-human-papillomavirus-hpv-shedding-and-oral-warts-after-beginning-haart-in-hiv-infected-a-132697https://curecurrent.com/trials/long-term-data-collection-from-participants-in-adult-aids-clinical-trials-132698https://curecurrent.com/trials/associations-outcomes-and-genomics-of-gb-virus-c-hepatitis-c-virus-and-human-immunodeficiency-virus-infection-132699https://curecurrent.com/trials/phase-iia-dose-ranging-study-of-gsk1349572-in-hiv-1-infected-adults-132700https://curecurrent.com/trials/safety-and-efficacy-study-of-twhf-in-hiv-patients-with-poor-immune-responses-132701https://curecurrent.com/trials/when-to-start-anti-hiv-drugs-in-children-infected-with-hiv-the-predict-study-132702https://curecurrent.com/trials/gene-therapy-chemotherapy-and-peripheral-stem-cell-transplantation-in-treating-patients-with-hiv-related-non-hodgkin-s-l-132703https://curecurrent.com/trials/group-psychotherapy-for-people-with-hiv-132704https://curecurrent.com/trials/a-study-of-the-once-daily-combination-of-etravirine-and-darunavir-ritonavir-as-dual-therapy-in-early-treatment-experienc-132705https://curecurrent.com/trials/safety-and-immunogenicity-study-of-a-dna-priming-and-mva-boosting-strategy-of-hiv-vaccine-132706https://curecurrent.com/trials/group-therapies-for-reducing-hiv-risk-behavior-in-women-who-have-survived-childhood-sexual-abuse-132707https://curecurrent.com/trials/kaletra-sex-gender-pharmacokinetics-pk-study-132708https://curecurrent.com/trials/safety-of-acidform-lubricant-in-hiv-uninfected-women-132709https://curecurrent.com/trials/subclinical-atherosclerosis-in-hiv-infected-patients-132710https://curecurrent.com/trials/a-tailored-interactive-website-for-promoting-condom-use-among-young-adults-132711https://curecurrent.com/trials/th9507-in-patients-with-hiv-associated-lipodystrophy-132712https://curecurrent.com/trials/observational-study-of-male-circumcision-using-prepex-device-132713https://curecurrent.com/trials/cdc-hiv-testing-guidelines-unresolved-ethical-concerns-132714https://curecurrent.com/trials/an-immunologic-study-of-treatment-naive-hiv-patients-starting-a-darunavir-ritonavir-or-efavirenz-based-haart-132715https://curecurrent.com/trials/comparison-of-the-qt-qtc-interval-between-an-outpatient-hiv-infected-population-on-antiretroviral-therapy-and-two-large-132716https://curecurrent.com/trials/hiv-risk-reduction-behavioral-intervention-for-commercial-sex-workers-in-yerevan-armenia-132717https://curecurrent.com/trials/paradoxical-tuberculosis-immune-reconstitution-inflammatory-syndrome-tb-iris-treatment-trial-132718https://curecurrent.com/trials/role-of-positive-affect-in-adjustment-to-hiv-132719https://curecurrent.com/trials/utilization-of-hiv-drug-resistance-testing-in-treatment-experienced-patients-utilize-study-132720https://curecurrent.com/trials/studies-of-influenza-vaccine-and-tetanus-pneumococcal-vaccine-in-hiv-infected-patients-receiving-interleukin-2-132721https://curecurrent.com/trials/hiv-in-specific-parts-of-the-body-of-patients-who-are-changing-or-starting-potent-anti-hiv-drugs-132722https://curecurrent.com/trials/social-and-economic-outcomes-of-hiv-aids-care-and-treatment-in-hiv-infected-south-african-adults-132723https://curecurrent.com/trials/study-of-provider-computer-alerts-designed-to-improve-delivery-of-hiv-care-132724https://curecurrent.com/trials/trial-embedded-in-an-electronic-personal-medical-health-records-132725https://curecurrent.com/trials/adherence-improvement-measure-aim-system-132726https://curecurrent.com/trials/the-effects-of-combination-anti-hiv-medication-on-human-papillomavirus-hpv-in-hiv-infected-women-132727https://curecurrent.com/trials/controlling-acute-or-early-hiv-infection-with-antiretroviral-drugs-without-a-candidate-vaccine-as-reported-previously-th-132728https://curecurrent.com/trials/a-simplification-study-of-unboosted-reyataz-with-epzicom-assure-132729https://curecurrent.com/trials/acute-hiv-infection-observational-study-132730https://curecurrent.com/trials/horizons-hiv-intervention-132731https://curecurrent.com/trials/hiv-prevention-for-african-american-teens-132732https://curecurrent.com/trials/identifying-genes-that-predict-risk-of-developing-cervical-intraepithelial-neoplasia-or-invasive-cervical-cancer-132733https://curecurrent.com/trials/imara-adapting-sihle-for-detained-african-american-adolescent-females-132734https://curecurrent.com/trials/modified-directly-observed-antiretroviral-therapy-132735https://curecurrent.com/trials/antidepressant-medication-plus-directly-observed-therapy-for-improving-adherence-to-antiretroviral-therapy-132736https://curecurrent.com/trials/computerized-hiv-sexually-transmitted-disease-std-prevention-program-132737https://curecurrent.com/trials/phase-ii-study-on-the-antiviral-activity-and-safety-of-bilr-355-bs-in-hiv-1-infected-nnrti-treated-patients-132738https://curecurrent.com/trials/open-label-study-of-nvp-cbv-treatment-in-women-who-have-received-sdnvp-for-the-pmtct-of-hiv-132739https://curecurrent.com/trials/immune-response-to-hepatitis-c-virus-132740https://curecurrent.com/trials/pharmacokinetic-pk-study-of-twice-daily-vs-once-daily-lamivudine-3tc-and-abacavir-abc-as-part-of-combination-antiretrovi-132741https://curecurrent.com/trials/a-pharmacokinetic-pk-study-of-a-combination-of-indinavir-ritonavir-and-amprenavir-132742https://curecurrent.com/trials/a-study-to-compare-three-different-formulations-of-tenofovir-1-gel-when-administered-rectally-132743https://curecurrent.com/trials/study-of-darunavir-r-tenofovir-emtricitabine-vs-darunavir-r-raltegravir-in-hiv-infected-antiretroviral-na-ve-subjects-132744https://curecurrent.com/trials/safety-study-of-tipranavir-co-administered-with-low-dose-ritonavir-tpv-r-in-patients-with-advanced-hiv-1-infection-and-l-132745https://curecurrent.com/trials/a-study-of-single-dose-nevirapine-nvp-combined-with-combivir-for-the-prevention-of-mother-to-child-transmission-pmtct-tr-132746https://curecurrent.com/trials/effectiveness-of-a-community-level-hiv-std-prevention-intervention-in-promoting-safer-sexual-behaviors-in-high-risk-popu-132747https://curecurrent.com/trials/an-study-to-investigate-the-recovery-excretion-and-pharmacokinetics-of-14c-gsk1265744-administered-as-a-single-oral-dose-132748https://curecurrent.com/trials/a-randomised-trial-to-evaluate-the-antiviral-efficacy-and-safety-of-treatment-with-500-mg-tipranavir-tpv-plus-100-mg-or-132749https://curecurrent.com/trials/quality-of-life-and-changes-in-metabolism-of-lipids-and-glucose-after-switching-to-a-nevirapine-based-regimen-in-hiv-pat-132750https://curecurrent.com/trials/trial-to-evaluate-steady-state-pharmacokinetic-parameters-efficacy-and-safety-of-nevirapine-in-antiretroviral-drug-na-ve-132751https://curecurrent.com/trials/pharmacokinetic-study-of-interaction-between-nevirapine-and-methadone-in-hiv-1-infected-opioid-dependent-adults-132752https://curecurrent.com/trials/the-effect-of-intermittent-rifampicin-on-raltegravir-132753https://curecurrent.com/trials/biomarkers-of-protocol-compliance-and-product-adherence-132754https://curecurrent.com/trials/a-phase-2-study-of-pf-00232798-in-hiv-positive-patients-132755https://curecurrent.com/trials/study-to-evaluate-safety-and-immunogenicity-of-vpm1002-in-comparison-with-bcg-in-newborn-infants-in-south-africa-132756https://curecurrent.com/trials/rwanda-selenium-supplementation-clinical-trial-132757https://curecurrent.com/trials/pharmacokinetics-of-the-tablet-formulation-of-lopinavir-r-as-standard-and-increased-dosage-during-pregnancy-132758https://curecurrent.com/trials/randomized-control-trial-copper-intrauterine-device-and-depo-medroxyprogesterone-acetate-dmpa-of-hiv-women-in-malawi-132759https://curecurrent.com/trials/establishing-effectiveness-of-daily-co-trimoxazole-prophylaxis-for-prevention-of-malaria-in-pregnancy-132760https://curecurrent.com/trials/growth-hormone-in-the-treatment-of-hiv-associated-wasting-132761https://curecurrent.com/trials/a-study-in-asymptomatic-hiv-infected-patients-to-investigate-pharmacodynamics-pharmacokinetics-safety-and-toleration-of-132762https://curecurrent.com/trials/interactions-between-hiv-and-malaria-in-african-children-132763https://curecurrent.com/trials/safety-and-efficacy-of-telaprevir-in-combination-with-peginterferon-alfa-2a-and-ribavirin-in-subjects-co-infected-with-h-132764https://curecurrent.com/trials/trial-of-maraviroc-uk-427-857-in-combination-with-zidovudine-lamivudine-versus-efavirenz-in-combination-with-zidovudine-132765https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-the-prepextm-device-for-rapid-scale-up-of-adult-mc-programs-in-zimbabwe-132766https://curecurrent.com/trials/blood-levels-of-abacavir-in-hiv-infected-adolescents-132767https://curecurrent.com/trials/safety-and-efficacy-of-the-prepex-device-circumcision-when-performed-by-nurses-132768https://curecurrent.com/trials/comparing-the-prepex-device-to-surgical-mc-for-rapid-scale-up-of-mc-in-resource-limited-setting-132769https://curecurrent.com/trials/long-term-effects-of-hiv-exposure-and-infection-in-children-132770https://curecurrent.com/trials/a-study-on-the-effect-of-high-calorie-infant-formula-on-growth-and-nutrition-in-hiv-infected-infants-132771https://curecurrent.com/trials/anti-hiv-drug-regimens-with-or-without-protease-inhibitors-and-drug-level-monitoring-in-hiv-infected-adolescents-132772https://curecurrent.com/trials/the-effects-of-anti-hiv-therapy-on-the-immune-systems-of-children-and-young-adults-infected-with-hiv-132773https://curecurrent.com/trials/a-study-to-collect-information-about-hiv-positive-pregnant-women-and-their-babies-132774https://curecurrent.com/trials/stopping-and-restarting-anti-hiv-drugs-in-children-and-adolescents-with-low-blood-levels-of-hiv-132775https://curecurrent.com/trials/zidovudine-and-lamivudine-given-once-versus-twice-daily-132776https://curecurrent.com/trials/a-comparison-of-two-caloric-supplements-in-the-prevention-of-weight-loss-in-patients-with-aids-who-take-daily-multivitam-132777https://curecurrent.com/trials/two-stage-tuberculin-ppd-skin-testing-in-individuals-with-human-immunodeficiency-virus-hiv-infection-132778https://curecurrent.com/trials/the-safety-and-effectiveness-of-adefovir-dipivoxil-in-the-treatment-of-hiv-infected-patients-132779https://curecurrent.com/trials/a-study-of-psychosocial-and-behavioral-determinants-of-differential-rates-of-participant-compliance-in-cpcra-protocols-132780https://curecurrent.com/trials/a-study-of-two-adherence-plans-to-help-hiv-positive-patients-take-their-medications-correctly-132781https://curecurrent.com/trials/a-registry-of-tuberculosis-cases-in-the-cpcra-132782https://curecurrent.com/trials/a-comparison-of-two-anti-hiv-treatment-plans-132783https://curecurrent.com/trials/a-pilot-study-of-the-short-term-effects-of-antiretroviral-management-based-on-plasma-genotypic-antiretroviral-resistance-132784https://curecurrent.com/trials/tmc125-tidp2-c238-an-exploratory-pharmacokinetics-safety-and-anti-hiv-activity-study-of-etravirine-etr-when-given-with-b-132785https://curecurrent.com/trials/maternal-determinants-of-hiv-exposed-and-hiv-unexposed-fetal-growth-birth-outcomes-and-early-infant-growth-132786https://curecurrent.com/trials/effectiveness-of-acyclovir-in-suppressing-hiv-viral-load-in-women-coinfected-with-hiv-and-herpes-simplex-virus-type-2-hs-132787https://curecurrent.com/trials/vertical-transmission-study-132788https://curecurrent.com/trials/estimating-the-incidence-of-hiv-infection-among-men-who-have-sex-with-men-in-peru-and-ecuador-132789https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-hodgkin-s-disease-and-hiv-infection-132790https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-hiv-related-non-hodgkin-s-lymphoma-132791https://curecurrent.com/trials/chemotherapy-and-radiation-therapy-in-treating-patients-with-hiv-related-primary-central-nervous-system-lymphoma-132792https://curecurrent.com/trials/combination-chemotherapy-plus-filgrastim-in-treating-patients-with-hiv-related-non-hodgkin-s-lymphoma-132793https://curecurrent.com/trials/rituximab-plus-combination-chemotherapy-in-treating-patients-with-hiv-related-non-hodgkin-s-lymphoma-132794https://curecurrent.com/trials/antiviral-therapy-in-treating-patients-with-slowly-progressing-hiv-related-kaposi-s-sarcoma-132795https://curecurrent.com/trials/the-neurocognitive-sub-study-of-encore1-132796https://curecurrent.com/trials/comparison-of-treatment-simplification-by-lpv-r-vs-current-treatment-continuation-in-hiv-infected-patients-132797https://curecurrent.com/trials/vitamin-d-dose-finding-study-132798https://curecurrent.com/trials/comparisons-of-serologic-response-of-early-syphilis-132799https://curecurrent.com/trials/motivating-hiv-women-risk-reduction-and-art-adherence-132800https://curecurrent.com/trials/efficacy-and-safety-study-of-miconazole-lauriad-to-treat-oropharyngeal-candidiasis-in-hiv-patients-132801https://curecurrent.com/trials/prevention-of-lipoatrophy-in-patients-treated-with-lopinavir-ritonavir-in-monotherapy-versus-zdv-3tc-abc-132802https://curecurrent.com/trials/a-feasibility-study-of-co-administering-combination-antiretroviral-therapy-cart-and-r-epoch-chemotherapy-for-the-managem-132803https://curecurrent.com/trials/long-term-atazanavir-experience-in-a-high-hiv-caseload-primary-care-practice-in-sydney-australia-132804https://curecurrent.com/trials/maraviroc-immune-recovery-study-132805https://curecurrent.com/trials/safety-and-immune-response-assessment-study-of-killed-whole-hiv-1-vaccine-sav001-h-in-chronic-hiv-1-infected-patients-132806https://curecurrent.com/trials/intervention-to-retain-hiv-positive-patients-in-medical-care-132807https://curecurrent.com/trials/safety-of-and-immune-response-to-prime-boost-vaccine-regimens-in-healthy-hiv-1-uninfected-ad5-seronegative-adults-132808https://curecurrent.com/trials/efavirenz-and-lamivudine-zidovudine-for-treatment-naive-hiv-infected-adults-in-senegal-132809https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-a-protease-inhibitor-and-of-interleukin-2-il-2-in-the-treatment-of-early-hiv-infection-132810https://curecurrent.com/trials/neighborhoods-networks-depression-and-hiv-risk-132811https://curecurrent.com/trials/study-on-long-term-outcomes-of-atazanavir-in-antiretroviral-na-ve-human-immunodeficiency-virus-hiv-patients-in-real-life-132812https://curecurrent.com/trials/evaluation-of-an-intervention-on-adherence-to-highly-active-antiretroviral-therapy-haart-in-hiv-infected-adults-132813https://curecurrent.com/trials/tmc114-tidp3-c182-a-study-to-compare-the-oral-bioavailability-of-a-800-mg-prototype-tablet-formulation-of-darunivar-drv-132814https://curecurrent.com/trials/a-phase-i-open-label-trial-to-explore-the-pharmacokinetics-safety-and-tolerability-of-tmc278-rilpivirine-25-mg-once-dail-132815https://curecurrent.com/trials/a-randomized-dose-ranging-study-of-alferon-ldo-in-asymptomatic-hiv-subjects-132816https://curecurrent.com/trials/novel-interventions-in-hiv-1-infection-132817https://curecurrent.com/trials/novel-measures-and-theory-of-pediatric-antiretroviral-therapy-adherence-in-uganda-132818https://curecurrent.com/trials/safety-and-immunogenicity-study-of-hiv-mag-vaccine-il-12-and-ad35-grin-env-in-hiv-uninfected-volunteers-132819https://curecurrent.com/trials/home-based-versus-partner-friendly-clinic-testing-to-enhance-male-partner-hiv-1-testing-during-pregnancy-132820https://curecurrent.com/trials/nevirapine-vs-ritonavir-boosted-lopinavir-in-art-naive-hiv-infected-adults-in-a-resource-limited-setting-132821https://curecurrent.com/trials/russian-labor-migrant-hiv-prevention-trial-132822https://curecurrent.com/trials/hsv-2-suppression-to-reduce-hiv-1-levels-in-hiv-1-co-infected-persons-132823https://curecurrent.com/trials/hsv-2-suppression-to-reduce-hiv-1-levels-in-hiv-1-hsv-2-co-infected-men-132824https://curecurrent.com/trials/effectiveness-of-a-telephone-intervention-program-in-improving-depression-coping-and-family-functioning-in-hiv-infected-132825https://curecurrent.com/trials/cognitive-behavioral-therapy-combined-with-antidepressants-to-reduce-hiv-risk-and-drug-relapse-among-depressed-intraveno-132826https://curecurrent.com/trials/antidepressant-medication-for-reducing-hiv-risk-behavior-in-depressed-intravenous-drug-users-132827https://curecurrent.com/trials/infant-male-circumcision-in-gaborone-botswana-and-surrounding-areas-feasibility-safety-and-acceptability-132828https://curecurrent.com/trials/using-implementation-intentions-to-increase-safe-sex-practices-in-msm-132829https://curecurrent.com/trials/immune-response-to-bivalent-and-tetravalent-human-papillomavirus-vaccine-in-hiv-infected-adults-132830https://curecurrent.com/trials/thalidomide-in-treating-patients-with-hiv-associated-kaposi-s-sarcoma-132831https://curecurrent.com/trials/safety-study-of-the-prepex-device-for-non-surgical-adult-male-circumcision-during-phased-in-national-implementation-in-a-132832https://curecurrent.com/trials/assessment-of-the-effectiveness-of-new-clinical-guidelines-for-differential-diagnosis-and-management-of-common-hiv-aids-132833https://curecurrent.com/trials/raltegravir-isentress-mk-0518-and-hiv-1-infected-cd4-cells-during-acute-early-hiv-1-132834https://curecurrent.com/trials/hiv-1-peptide-immunisation-of-individuals-in-west-africa-to-prevent-disease-132835https://curecurrent.com/trials/metabolic-and-psychological-changes-associated-with-menopause-among-women-with-hiv-132836https://curecurrent.com/trials/increasing-viral-testing-in-the-emergency-department-132837https://curecurrent.com/trials/safety-and-efficacy-study-of-serostim-human-immunodeficiency-virus-associated-adipose-redistribution-syndrome-132838https://curecurrent.com/trials/pre-hiv-test-counseling-intervention-to-reduce-hiv-infection-risk-behavior-in-men-who-are-not-hiv-infected-132839https://curecurrent.com/trials/safety-and-efficacy-of-an-antibody-to-ccr5-in-individuals-with-hiv-who-are-not-currently-on-antiretroviral-therapy-132840https://curecurrent.com/trials/study-on-interleukin-7-cyt107-in-hiv-patients-132841https://curecurrent.com/trials/case-control-viramune-nevirapine-toxicogenomics-study-132842https://curecurrent.com/trials/using-multimedia-technologies-to-disseminate-an-hiv-prevention-132843https://curecurrent.com/trials/enfuvirtide-current-protease-inhibitor-switch-to-prezista-darunavir-ritonavir-tmc125-in-hiv-patients-with-enfuvirtide-si-132844https://curecurrent.com/trials/reasons-for-non-treatment-of-hepatitis-c-in-hcv-mono-infected-patients-versus-hcv-hiv-co-infected-patients-in-a-universi-132845https://curecurrent.com/trials/the-treatment-of-insomnia-in-patients-with-hiv-disease-132846https://curecurrent.com/trials/evaluation-of-the-impact-of-mobile-phone-messages-on-art-and-pmtct-adherence-in-mozambique-132847https://curecurrent.com/trials/virologic-and-immunologic-activity-of-continued-lamivudine-3tc-vs-delavirdine-dlv-in-combination-with-indinavir-idv-and-132848https://curecurrent.com/trials/a-study-to-evaluate-high-protein-supplementation-in-hiv-positive-patients-with-stable-weight-loss-132849https://curecurrent.com/trials/effects-of-treatment-changes-on-fat-wasting-in-the-arms-and-legs-of-hiv-patients-132850https://curecurrent.com/trials/effects-of-changing-hiv-therapy-at-lower-versus-higher-viral-loads-132851https://curecurrent.com/trials/effect-of-anti-hiv-therapy-haart-on-hiv-levels-in-the-lungs-and-on-lung-cell-inflammation-in-hiv-infected-patients-132852https://curecurrent.com/trials/blood-vessel-function-in-hiv-infected-patients-taking-anti-hiv-drugs-132853https://curecurrent.com/trials/simplified-drug-regimens-for-hiv-patients-in-actg-388-or-patients-who-responded-to-a-first-potent-combination-regimen-132854https://curecurrent.com/trials/nerve-damage-in-patients-with-hiv-infection-who-have-been-treated-with-anti-hiv-drugs-132855https://curecurrent.com/trials/preliminary-study-of-safety-and-efficacy-of-policosanol-132856https://curecurrent.com/trials/pharmacokinetics-of-tenofovir-and-tenofovir-diphosphate-emtricitabine-and-emtricitabine-triphosphate-and-rilpivirine-onc-132857https://curecurrent.com/trials/improving-hiv-prevention-skills-in-people-with-serious-mental-illnesses-132858https://curecurrent.com/trials/randomized-study-on-multiple-cycles-of-interleukin-7-in-hiv-patients-immune-non-responders-132859https://curecurrent.com/trials/probiotics-in-the-management-of-necrotizing-enterocolitis-in-hiv-exposed-premature-infants-132860https://curecurrent.com/trials/metformin-and-rosiglitazone-alone-or-in-combination-in-hiv-infected-patients-with-insulin-and-fat-abnormalities-132861https://curecurrent.com/trials/the-prevalence-of-hiv-drug-resistance-and-transmission-risk-in-opioid-agonist-treatment-132862https://curecurrent.com/trials/non-alcoholic-fatty-liver-disease-nafld-in-hiv-the-role-of-nutritional-interventions-132863https://curecurrent.com/trials/to-determine-if-chromium-nicotinate-supplementation-will-improve-insulin-resistance-in-hiv-patients-with-metabolic-abnor-132864https://curecurrent.com/trials/acceptability-of-depo-subq-in-uniject-132865https://curecurrent.com/trials/efficacy-and-safety-of-2-raltegravir-doses-in-naive-hiv-1-infected-patients-receiving-rifampin-for-active-tuberculosis-132866https://curecurrent.com/trials/pharmacokinetics-of-rifabutin-combined-with-antiretroviral-therapy-in-patients-with-tb-hiv-co-infection-in-vietnam-132867https://curecurrent.com/trials/evaluation-of-the-extension-at-community-level-of-safe-male-circumcision-anrs-12126-orange-farm-2-132868https://curecurrent.com/trials/sustainable-hiv-risk-reduction-strategies-for-cj-systems-132869https://curecurrent.com/trials/nutritional-status-among-na-ve-hiv-infected-patients-and-hiv-infected-patients-receiving-highly-active-antiretroviral-th-132870https://curecurrent.com/trials/scope-strategies-to-combine-prep-with-prevention-efforts-132871https://curecurrent.com/trials/a-prospective-observational-study-of-the-clinical-performance-of-femplant-in-pakistan-132872https://curecurrent.com/trials/a-study-of-the-drug-interactions-between-a-hormonal-emergency-contraception-and-an-hiv-medication-132873https://curecurrent.com/trials/darunavir-levels-virological-efficacy-proviral-adn-and-resistances-in-patients-on-darunavir-ritonavir-monotherapy-132874https://curecurrent.com/trials/a-proof-of-concept-study-to-evaluate-the-antiviral-activity-safety-and-pharmacokinetics-of-the-ccr5-antagonist-tbr-652-i-132875https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-cenicriviroc-cvc-in-combination-with-truvada-or-sustiva-plus-truvada-in-hiv-1-infect-132876https://curecurrent.com/trials/information-about-hiv-transmission-and-circumcision-on-subsequent-sexual-behavior-and-the-demand-for-circumcision-132877https://curecurrent.com/trials/hiv-testing-womens-attitudes-on-hiv-vaccine-trials-132878https://curecurrent.com/trials/potential-for-drug-drug-interactions-between-boceprevir-and-etravirine-in-hiv-hepatitis-c-virus-negative-volunteers-132879https://curecurrent.com/trials/enhancing-oral-health-care-use-by-hiv-positive-individuals-132880https://curecurrent.com/trials/a-phase-2-study-to-evaluate-pharmacokinetics-safety-and-efficacy-of-tmc114-ritonavir-rtv-in-human-immunodeficiency-virus-132881https://curecurrent.com/trials/raltegravir-augmentation-on-persistent-central-nervous-system-cns-immunoactivation-in-treated-hiv-1-patients-132882https://curecurrent.com/trials/gsk1349572-exposure-in-blood-seminal-fluid-and-rectal-fluid-and-tissue-in-healthy-male-subjects-132883https://curecurrent.com/trials/a-study-in-underrepresented-patient-population-or-regimen-tolerability-support-132884https://curecurrent.com/trials/a-prospective-observational-study-of-the-performance-of-zarin-in-kenya-132885https://curecurrent.com/trials/a-peer-oriented-hiv-prevention-outreach-program-for-individuals-at-high-risk-for-hiv-and-other-stis-132886https://curecurrent.com/trials/efficacy-and-safety-of-tdf-3tc-efv-in-adults-with-hiv-hbv-coinfection-132887https://curecurrent.com/trials/a-study-to-compare-brachial-artery-reactivity-and-cardiovascular-risk-of-a-treatment-simplification-by-darunavir-ritonav-132888https://curecurrent.com/trials/assisting-hiv-infected-mothers-in-disclosing-their-serostatus-to-their-children-132889https://curecurrent.com/trials/tmc114-c211-trial-of-an-investigational-protease-inhibitor-tmc114-with-ritonavir-tmc114-r-in-hiv-1-infected-patients-who-132890https://curecurrent.com/trials/study-of-treatment-of-antiretroviral-naive-hiv-1-infected-patients-comparing-tenofovir-disoproxil-fumarate-administered-132891https://curecurrent.com/trials/pilot-trial-of-novel-circumcision-device-132892https://curecurrent.com/trials/cognitive-behavioral-therapy-to-help-hiv-infected-adults-with-depression-to-adhere-to-antiretroviral-therapy-132893https://curecurrent.com/trials/antiviral-therapy-in-treating-patients-with-kaposi-s-sarcoma-with-or-without-hiv-infection-132894https://curecurrent.com/trials/a-study-with-tmc125-in-human-immunodeficiency-virus-hiv-type-1-infected-patients-who-were-treated-with-tmc125-arm-in-a-s-132895https://curecurrent.com/trials/safety-and-immunogenicity-of-recombinant-hiv-vaccines-for-hiv-aids-132896https://curecurrent.com/trials/the-switch-study-the-role-of-lamivudine-emtricitabine-3tc-ftc-in-antiretroviral-regimens-132897https://curecurrent.com/trials/therapy-targeting-depression-and-hiv-treatment-adherence-the-triad-study-132898https://curecurrent.com/trials/adherence-intervention-for-people-with-low-literacy-132899https://curecurrent.com/trials/hsv-oral-reactivation-in-children-132900https://curecurrent.com/trials/interaction-between-etravirine-or-darunavir-ritonavir-and-artemether-lumefantrine-132901https://curecurrent.com/trials/therapeutic-intensification-plus-immunomodulation-in-hiv-infected-patients-132902https://curecurrent.com/trials/diagnosis-and-treatment-of-co-infection-with-human-immunodeficiency-virus-latent-tuberculosis-infection-hiv-tbl-132903https://curecurrent.com/trials/a-study-to-determine-the-antiviral-activity-of-tmc310911-when-administered-with-ritonavir-in-treatment-naive-human-immun-132904https://curecurrent.com/trials/rosuvastatin-to-decrease-residual-immune-activation-in-hiv-infection-132905https://curecurrent.com/trials/trial-of-methadone-maintenance-versus-methadone-detox-in-jail-132906https://curecurrent.com/trials/safety-immunogenicity-of-13vpnc-in-hiv-infected-subjects-aged-18-or-older-who-were-previously-immunized-with-23vps-132907https://curecurrent.com/trials/taste-assessment-study-of-2-atazanavir-powder-formulations-in-healthy-subjects-132908https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-memantine-in-combination-with-anti-hiv-drugs-to-treat-aids-dementia-complex-adc-132909https://curecurrent.com/trials/hiv-prevention-program-for-patients-receiving-care-at-a-sexually-transmitted-diseases-clinic-132910https://curecurrent.com/trials/pharmacokinetic-interactions-between-antiretroviral-agents-and-antimalarial-drug-combinations-132911https://curecurrent.com/trials/drug-interaction-study-between-antimalarial-and-anti-hiv-medications-132912https://curecurrent.com/trials/immunogenicity-safety-and-tolerability-of-mf59-adjuvanted-versus-non-adjuvanted-influenza-vaccines-in-patients-with-hiv-132913https://curecurrent.com/trials/halofuginone-hydrobromide-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132914https://curecurrent.com/trials/an-innovative-hiv-prevention-intervention-using-social-networking-technology-132915https://curecurrent.com/trials/risk-reduction-intervention-for-vulnerable-young-adult-males-132916https://curecurrent.com/trials/intervention-targeting-medication-adherence-and-methamphetamine-use-in-hiv-positive-men-ace-132917https://curecurrent.com/trials/factors-affecting-adherence-to-anti-hiv-drug-regimens-in-children-and-adolescents-132918https://curecurrent.com/trials/emd-121974-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132919https://curecurrent.com/trials/rapid-hiv-tests-for-women-late-in-pregnancy-and-during-labor-132920https://curecurrent.com/trials/feasibility-of-a-hepatitis-c-virus-hcv-decision-making-intervention-among-hiv-infected-adults-132921https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cells-for-immune-reconstitution-in-hiv-infected-patients-132922https://curecurrent.com/trials/a-trial-examining-the-efficacy-of-escitalopram-oxalate-upon-depressive-symptoms-and-fatigue-in-hiv-seropositive-women-132923https://curecurrent.com/trials/entecavir-intensification-for-persistent-hbv-viremia-in-hiv-hbv-infection-132924https://curecurrent.com/trials/impact-of-a-computer-assisted-sbirt-program-in-an-hiv-care-setting-132925https://curecurrent.com/trials/moxifloxacin-as-part-of-a-multi-drug-regimen-for-tuberculosis-132926https://curecurrent.com/trials/antiretroviral-therapy-for-advanced-hiv-disease-in-south-africa-132927https://curecurrent.com/trials/observational-study-of-blood-treated-with-cytolin-132928https://curecurrent.com/trials/a-single-dose-escalation-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-intramuscular-and-subcutan-132929https://curecurrent.com/trials/a-school-based-hiv-std-prevention-program-to-reduce-risky-sexual-behaviors-among-adolescents-in-liberia-132930https://curecurrent.com/trials/prevention-of-milk-borne-transmission-of-hiv-1c-in-botswana-132931https://curecurrent.com/trials/pilot-study-to-assess-gut-mucosal-b-cells-in-individuals-with-hcv-and-hiv-132932https://curecurrent.com/trials/hiv-diagnosis-in-hospitalized-malawian-infants-132933https://curecurrent.com/trials/a-randomized-prospective-study-of-the-efficacy-safety-and-tolerability-of-two-doses-of-gw433908ritonavir-given-with-abac-132934https://curecurrent.com/trials/maintenance-boosted-lopinavir-monotherapy-following-salvage-protease-inhibitor-pi-based-regimen-in-hiv-with-non-nucleosi-132935https://curecurrent.com/trials/the-intensive-pharmacokinetics-sub-study-of-encore1-encore1-pk-132936https://curecurrent.com/trials/the-efavirenz-efv-central-nervous-system-exposure-sub-study-of-encore1-132937https://curecurrent.com/trials/trial-of-impact-of-crime-group-intervention-for-jail-inmates-132938https://curecurrent.com/trials/fosamprenavir-in-pts-with-hepatic-impairment-132939https://curecurrent.com/trials/evaluation-of-cardiovascular-effects-of-smoking-cessation-in-hiv-patients-132940https://curecurrent.com/trials/evaluation-of-re-entry-values-and-mindfulness-program-revamp-with-jail-inmates-132941https://curecurrent.com/trials/jail-based-impact-of-crime-intervention-132942https://curecurrent.com/trials/a-phase-i-trial-of-hiv-1-c4-v3-polyvalent-peptide-vaccine-in-hiv-1-infected-persons-132943https://curecurrent.com/trials/treatment-perception-of-qd-once-a-day-dosed-kaletra-tablets-132944https://curecurrent.com/trials/non-interventional-study-on-use-of-darunavir-with-ritonavir-in-clinical-practice-132945https://curecurrent.com/trials/mentor-mothers-a-sustainable-family-intervention-in-south-african-townships-132946https://curecurrent.com/trials/reducing-ethnic-health-disparities-motivating-hiv-latinos-to-quit-smoking-132947https://curecurrent.com/trials/hiv-prevention-with-the-mentally-ill-132948https://curecurrent.com/trials/determining-characteristics-and-behaviors-of-adolescent-women-regarding-hiv-risk-and-microbicide-trial-participation-132949https://curecurrent.com/trials/raltegravir-based-antiretroviral-therapy-for-resistant-hiv-1-infection-132950https://curecurrent.com/trials/efficacy-and-safety-of-tenofovir-plus-lamivudine-plus-efavirenz-regimen-as-first-line-antiretroviral-therapy-132951https://curecurrent.com/trials/maraviroc-in-immunological-non-responder-inr-hiv-1-infected-subjects-132952https://curecurrent.com/trials/impact-of-menstrual-cycle-on-antiretroviral-pharmacokinetics-in-hiv-infected-women-132953https://curecurrent.com/trials/the-effects-of-nutritional-supplementation-and-drug-abuse-on-hiv-132954https://curecurrent.com/trials/study-to-evaluate-switching-from-a-regimen-consisting-of-the-efavirenz-emtricitabine-tenofovir-disoproxil-fumarate-singl-132955https://curecurrent.com/trials/drug-use-investigation-on-zithromac-azithromycin-in-hiv-patients-132956https://curecurrent.com/trials/parent-provider-intervention-for-improving-medication-adherence-in-children-with-attention-deficit-hyperactivity-disorde-132957https://curecurrent.com/trials/genotype-based-personalized-prescription-of-nevirapine-132958https://curecurrent.com/trials/pharmacokinetic-interactions-between-telaprevir-and-un-boosted-atazanavir-132959https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-calcium-carbonate-and-ferrous-fumarate-on-pharmacokinetics-of-dolutegravir-in-healthy-132960https://curecurrent.com/trials/modified-directly-observed-therapy-for-improving-antiretroviral-therapy-adherence-in-people-with-hiv-132961https://curecurrent.com/trials/safety-study-of-uc-781-vaginal-microbicide-132962https://curecurrent.com/trials/a-study-to-assess-gw433908-fosamprenavir-containing-regimens-in-hiv-1-infected-subjects-132963https://curecurrent.com/trials/a-network-dyad-hiv-prevention-intervention-for-idu-s-1-132964https://curecurrent.com/trials/the-role-of-ampligen-in-strategic-therapeutic-intervention-sti-of-haart-132965https://curecurrent.com/trials/safety-and-efficacy-of-ampligen-in-the-treatment-of-hiv-patients-failing-haart-132966https://curecurrent.com/trials/evaluation-of-treatments-for-homeless-youths-132967https://curecurrent.com/trials/adult-sexual-risk-behavior-among-women-with-a-history-of-childhood-sexual-abuse-132968https://curecurrent.com/trials/share-safer-sex-counseling-program-for-changing-sexual-risk-behaviors-in-mexican-female-sex-workers-132969https://curecurrent.com/trials/faster-identification-of-tb-and-evaluation-of-drug-resistance-in-hiv-infected-people-132970https://curecurrent.com/trials/hiv-prevention-intervention-for-couples-132971https://curecurrent.com/trials/analysis-of-changes-in-adipose-tissue-of-patients-with-lipoatrophy-hiv-infection-treated-with-nucleoside-thymidine-after-132972https://curecurrent.com/trials/nutrition-intervention-in-drug-naive-hiv-infected-kenyan-women-and-their-children-132973https://curecurrent.com/trials/family-planning-through-dairy-cooperatives-132974https://curecurrent.com/trials/a-safety-and-efficacy-study-of-amdoxovir-in-hiv-1-treatment-experienced-subjects-132975https://curecurrent.com/trials/reducing-hiv-risk-among-pregnant-women-in-drug-treatment-132976https://curecurrent.com/trials/sleep-hiv-disease-progression-and-function-in-hiv-infected-children-and-adolescents-132977https://curecurrent.com/trials/single-dermavir-immunization-in-hiv-1-infected-patients-on-haart-132978https://curecurrent.com/trials/efficacy-and-safety-of-concomitant-use-of-nevirapine-and-rifampicin-with-hiv-tb-132979https://curecurrent.com/trials/impact-on-t-cell-immune-activation-and-inflammation-of-triptolide-woldifii-in-hiv-infected-immunological-non-responders-132980https://curecurrent.com/trials/lopinavir-r-monotherapy-versus-abacavir-lamivudine-and-lopinavir-r-for-limb-fat-recovery-in-persons-with-lipoatrophy-132981https://curecurrent.com/trials/garlic-in-hyperlipidemia-caused-by-haart-132982https://curecurrent.com/trials/progression-of-hiv-disease-under-low-dose-corticosteroids-132983https://curecurrent.com/trials/adolescent-drug-and-hiv-prevention-in-south-africa-132984https://curecurrent.com/trials/safety-and-efficacy-of-famciclovir-in-hiv1-positive-adults-with-recurrent-genital-herpes-132985https://curecurrent.com/trials/clinical-trial-open-label-randomised-in-order-to-compare-the-quality-of-life-for-those-vih-patients-that-start-with-mono-132986https://curecurrent.com/trials/safety-and-efficacy-of-kaletra-in-arv-therapy-experienced-patients-132987https://curecurrent.com/trials/project-power-adapting-project-safe-reducing-std-hiv-risk-in-women-prisoners-132988https://curecurrent.com/trials/db289-versus-tmp-smx-for-the-treatment-of-acute-pneumocystis-jiroveci-pneumonia-pcp-132989https://curecurrent.com/trials/antiviral-therapy-plus-either-peripheral-stem-cell-or-umbilical-cord-blood-transplantation-in-treating-patients-who-are-132990https://curecurrent.com/trials/motiv82change-an-hiv-prevention-study-for-young-latino-men-132991https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-steady-state-tmc278-on-the-pharmacokinetics-of-a-single-dose-of-digoxin-132992https://curecurrent.com/trials/a-study-to-assess-the-bioequivalence-of-darunavir-when-co-administrated-with-cobicistat-under-fed-and-fasted-conditions-132993https://curecurrent.com/trials/switch-from-combivir-or-trizivir-to-truvada-mitochondrial-effects-132994https://curecurrent.com/trials/alcohol-use-and-risky-sexual-behaviors-among-hiv-infected-subjects-in-kampala-uganda-132995https://curecurrent.com/trials/prevention-of-varicella-zoster-virus-vzv-reactivation-in-hiv-positive-individuals-enrolled-in-a-prospective-immunogenici-132996https://curecurrent.com/trials/an-automated-tailored-information-application-for-medication-health-literacy-132997https://curecurrent.com/trials/double-method-comparative-study-in-order-to-predict-the-use-of-co-receptors-from-type-1-hiv-phenotypic-study-trofile-est-132998https://curecurrent.com/trials/effects-of-2-initial-standard-antiretroviral-combinations-therapies-on-lipid-metabolism-132999https://curecurrent.com/trials/a-phase-i-study-of-modified-vaccinia-virus-ankara-mva-b-in-healthy-volunteers-at-low-risk-of-hiv-infection-133000https://curecurrent.com/trials/once-daily-antiretroviral-therapy-in-hiv-1-infected-patients-with-cd4-cell-counts-below-100-cells-mcl-133001https://curecurrent.com/trials/topotecan-hydrochloride-in-treating-children-with-meningeal-cancer-that-has-not-responded-to-previous-treatment-133002https://curecurrent.com/trials/a-study-comparing-4-doses-of-gw810781-versus-placebo-in-hiv-infected-patients-133003https://curecurrent.com/trials/a-community-health-worker-delivered-hiv-sti-prevention-intervention-for-internally-displaced-women-in-leogane-haiti-133004https://curecurrent.com/trials/safety-and-effectiveness-of-short-term-anti-hiv-drug-therapy-for-recent-hiv-1-infection-133005https://curecurrent.com/trials/evaluation-of-the-performance-of-the-nitrate-reductase-and-resazurin-titre-assay-for-the-detection-of-mycobacterium-tube-133006https://curecurrent.com/trials/a-study-to-compare-effectiveness-and-safety-of-darunavir-ritonavir-drv-rtv-800mg-100mg-once-daily-versus-drv-rtv-600mg-1-133007https://curecurrent.com/trials/clinical-study-of-tuti-16-in-asymptomatic-hiv-1-infected-subjects-thymon-11001-133008